Website is intended for physicians
Search:
Всего найдено: 35

Abstract:

Aim: was to study the efficacy and functionality of the Yukon Chrome PC stent in clinical practice.

Materials and methods: in 2021, a prospective, observational study of the safety, effectiveness of the Yukon Chrome PC stent, as well as its functionality during implantation in clinical practice, was launched on the basis of 25 domestic clinics. The study included 364 patients who underwent implantation of 495 Yukon Chrome PC stents. Mean age of patients was 62,8 years (from 33 to 89 years). Men were 263 (72,3%). The vast majority (82,4%) of patients were diagnosed with acute coronary syndrome (ACS): without ST segment elevation - 180 (49,45%) patients; with ST segment elevation - 120 (32,9%) patients. Unstable angina was verified in 22 (6%) patients. There were 42 (11,5%) patients with stable angina class 2-3.

Moderate tortuosity of vessels occurred in 27,7% of cases, while severe tortuosity of vessels occurred in 3,57% of cases. Moderate calcification was noted in 115 (31,5%) patients, severe/massive - in 23 (6,3%) cases. A complex lesion combining severe/moderate calcification and severe/moderate tortuosity of the target artery occurred in 79 (21,7%) patients.

Results: technical success of the procedure was achieved in 97,5% of cases. In one patient with severe calcification, the Yukon Chrome PC stent could not be inserted into the affected area. Attempts to implant another stent were also unsuccessful.

Depending on the number of implanted stents, the patients were distributed as follows: 3 stents were inplanted in 31 (8,5%) patients; 2 stents - 102 (28%) patients, 1 stent - 231 (63,5%) patients.

Bifurcation stenting using a two-stent technique was performed in 69 (19%) patients. Stenting of the left main was performed in 11 (3%) cases. Predilation was performed in 245 (67%) patients; postdilation - in 179 (49%) patients.

Conclusion: analysis of hospital results of implantation of Yukon Chrome PC stents indicates good flexibility and deliverability of stents even in patients with moderate and severe sheath calcification.

The overall assessment of the functional characteristics of the stent among endovascular surgeons who performed stenting is quite high.

 

authors: 

 

Abstract:

Introduction: the problem of the shortage of donor organs can be partially solved by expanding the donor selection criteria. The consequence of this is an increase in the risk of transmission of atherosclerotic lesions of the coronary arteries from the donor to the recipient. According to current publications, endovascular correction is the preferred treatment. Assessment of the hemodynamic significance of borderline stenosis of the coronary arteries in recipients, detected at the first coronary angiography in the early postoperative period, remains a topical issue.

Case report: article presents case report of results of endovascular correction of donor-associated lesion of coronary arteries in recipient under control of iFr.

Conclusion: due to the severity of patient's condition, the use of non-invasive methods for verifying myocardial ischemia is sharply limited, which determines the high importance of endovascular technologies for the physiological assessment of stenosis.

 

References

1.     Lee HY, Oh BH. Heart Transplantation in Asia. Circulation Journal. 2017; 81(5): 617-621.

https://doi.org/10.1253/circj.CJ-17-0162

2.     Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report. Focus Theme: Age. J Heart Lung Transplant. 2013; 32(10): 965-978.

3.     Sakhovsky SA, Izotov DA, Koloskova NN, et al. Angiograficheskaya otsenka ateroskleroticheskogo porazheniya koronarnikh arterii serdechnogo transplantata. Vestnik transplantologii i iskusstvennih organov. 2018; 20(4): 22-29 [In Russ].

https://doi.org/10.15825/1995-1191-2018-4-22-29

4.     Chestukhin VV, Ostroumov EN, Tyunyaeva IYu, et al. Bolezn’ koronarnikh arterii peresazhennogo serdtsa. Vozmozhnosti diagnostiki i lecheniya. Ocherki klinicheskoi transplantologii pod redakciei Got’e SV. M. 2009; 88-93 [In Russ].

5.     Darenskii DI, Gramovich VV, Zharova EA, et al. Diagnosticheskaya tsennost izmereniya momental’nogo rezerva krovotoka po sravneniyu s neinvazivnimi metodami viyavleniya ishemii miokarda pri otsenke funktsionalnoi znachimosti pogranichnikh stenozov koronarnikh arterii. Terapevticheskii arkhiv. 2017; 4: 15-21 [In Russ].

6.     Gramovich VV, Zharova EA, Mitroshkin MG, et al. Opredelenie porogovikh znachenii momental’nogo rezerva krovotoka pri otsenke funktsionalnoi znachimosti stenozov koronarnish arterii pogranichnoi stepeni tyazhesti s ispolzovaniem neinvazivnikh metodov verifikatsii ishemii miokarda v kachestve standarta. Evraziiskii kardiologicheskii zhurnal. 2016; 4: 34-41 [In Russ].

7.     Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. The New England Journal of Medicine. 2009; 360: 213-224.

https://doi.org/10.1056/NEJMoa0807611

8.     De Bruyne B, Pijls NH, Kalesan B, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367(11): 991-1001.

https://doi.org/10.1056/NEJMoa1205361

9.     Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. The New England Journal of Medicine. 2018; 379: 250-259.

https://doi.org/10.1056/NEJMoa1803538

10.   Barbato E, Toth GG, Johnson NP, et al. Prospective natural history study of coronary atherosclerosis using fractional flow reserve. Journal of the American College of Cardiology. 2016; 68(21): 2247-2255.

https://doi.org/10.1016/j.jacc.2016.08.055

11.   G?tberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PC. The New England Journal of Medicine. 2017; 376: 1813-23.

https://doi.org/10.1056/NEJMoa1616540

12.   Andell P, Berntorp K, Christiansen EH, et al. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and В Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. JACC: Cardiovascular Interventions. 2018; 11(20): 2084-2094.

https://doi.org/10.1016/j.jcin.2018.07.035

13.   Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. The New England Journal of Medicine. 2017; 376: 1824-1834.

https://doi.org/10.1056/NEJMoa1700445

14.   Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group; 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019; 40(2): 87-165.

https://doi.org/10.1093/eurheartj/ehy394

 

Abstract:

Introduction: development of software and hardware capabilities of modern computing systems has enabled three-dimensional (3D) modeling and 3D printing technology (medical prototyping) to become available for a wide range of healthcare specialists. Commercial software used for this purpose remains unavailable to private physicians and small institutions due to the high cost. However, there are freeware applications and affordable 3D printers that can also be used to create medical prototypes.

Aim: was to describe stages of creating of physical 3D models based on medical imaging data and to highlight main features of specialized software and to make an overview of main types of 3D printing used in medicine.

Material and methods: article describes process of creation of medical prototype, that can be divided on three main stages: 1) acquisition of medical imaging, obtained by ‘volumetric’ scanning methods (computed tomography (CT), magnetic-resonance imaging (MRI), 3D ultrasound (3D US)); 2) virtual 3D model making (on the basis of visualisation data) by segmentation, polygonal mesh extraction and correction; 3) 3D printing of virtual model by the chosen method of additive manufacturing, with or without post-processing.

Conclusion: medical prototypes with sufficient precision and physical properties are necessary for understanding of anatomical structure and surgical crew training and can be made with use of freely available software and inexpensive 3D printers.

 

References

1.     Luo H, Meyer-Szary О, Wang Z, Sabiniewicz R, Liu Y. Three-dimensional printing in cardiology: current applications and future challenges. Cardiol. J. 2017; 24 (4): 436–444.

2.     Vukicevic M, Mosadegh B, Min J K, Little S H. Cardiac 3D printing and its future directions. JACC Cardiovasc. Imaging. 2017; 10 (2): 171–184.

3.     Meier LM, Meineri ·M, Hiansen JQ, Horlick EM. Structural and congenital heart disease interventions: the role of three-dimensional printing. Neth Heart J. 2017; 25 (2): 65–75.

4.     Witschey WR, Pouch AM, McGarvey JR, Ikeuchi K, Contijoch F, Levack MM, Yushkevick PA, Sehgal CM, Jackson BM, Gorman RC, Gorman JH. Three-dimensional ultrasound-derived physical mitral valve modeling. Ann. Thorac. Surg. 2014; 98 (2): 691–694.

5.     Vukicevic M, Puperi DS, Grande-Allen KJ, Little SH. 3D Printed Modeling of the Mitral Valve for Catheter-Based Structural Interventions. Ann. Biomed. Eng. 2017; 45 (2): 508–519.

6.     Parimi M, Buelter J, Thanugundla V, Condoor S, Parkar N, Danon S, King W. Feasibility and Validity of Printing 3D Heart Models from Rotational Angiography. Pediatr. Cardiol. 2018; 39 (4): 653–658.

7.     Abudayyeh I, Gordon B, Ansari MM, Jutzy K, Stoletniy L, Hilliard A. A practical guide to cardiovascular 3D printing in clinical practice: Overview and examples. J. Interv. Cardiol. 2018; 31 (3): 375–383.

8.     Ripley B, Levin D, Kelil T, Hermsen JL, Kim S, Maki JH, Wilson GJ. 3D printing from MRI Data: Harnessing strengths and minimizing weaknesses. J.of Magnetic Resonance Imaging. 2016; 45 (3): 1–11.

9.     Wang J, Coles-Black J, Matalanis G, Chuen J. Innovations in cardiac surgery: techniques and applications of 3D printing. J. 3D Print. Med. 2018; 2 (4): 179–186.

10.   Nagibovich OA, Svistov DV, Peleshok SA, Korovin AE, Gorodkov EV. Appliance of 3D printing technology in medicine. Klin. patofiz. 2017; 23 (3): 14–22 [In Russ].

11.   Bagaturiya GO. Prospects for the use of 3D printing in planning of surgical operations. Med.: teorija i praktika. 2016; 1 (1): 26–35 [In Russ].

12.   Kim GB, Lee S, Kim H, Yang DH, Kim Y-H, Kyung YS, Kim C-S, Choi SH, Kim BJ, Ha H, Kwon SU, Kim N. Three-Dimensional Printing: Basic Principles and Applications in Medicine and Radiology. Korean J. of Radiol. 2016; 17): 182.

13.   Shi D, Liu K, Zhang X, Liao H, Chen X. Applications of three-dimensional printing technology in the cardiovascular field. Inter. and Emergency Med. 2015; 10: 769–780.

14.   Byrne N, Forte MV, Tandon A, Tandon A, Valverde I, Hussain T. A systematic review of image segmentation methodology, used in the additive manufacture of patient specific 3D printed models of the cardiovascular system. JRSM Cardiovasc. Disease. 2016; 5 (0): 1–9.

15.   Valverde I. Three-dimensional printed cardiac models: applications in the field of medical education, cardiovascular surgery, and structural heart interventions. Revista Espaсola de Cardiologнa (English Edition). 2017; 70 (4): 282–291.

16.   Karyakin NN, Shubnyakov II, Denisov AO, Kachko A V, Alyev RV, Gorbatov RO. Regulatory concerns about medical device manufacturing using 3D printing: current state of the issue. Travmatol. i ortop. Ross. 2018; 24 (4): 129–136 [In Russ].

 

Abstract

Introduction: article presents the first experience and long-term results of using domestic coronary balloon-expandable stents with a bioinert carbon coating, «Nanomed».

Aim: was to evaluate long-term results of using domestic coronary balloon-expandable stents with bioinert linear chain carbon coating (BLCCC), «Nanomed».

Materials and methods: the study included 387 patients, suffering from coronary heart disease, who underwent endovascular myocardial revascularization from 2016 to 2018, with implantation of coronary balloon-expandable stents with BLCCC by the Nanomed company, Penza. The control group included 320 patients who underwent endovascular myocardial revascularization with implantation of coronary balloon-expandable cobalt-chromium stents «MSure Cr» of the company «Multimedics», during the same period. A comparative estimation of long-term results was carried out on the basis of a study of the overall frequency of repeated myocardial revascularization; repeated interventions on the target vessel; the frequency of interventions on other coronary arteries with the progression of atherosclerosis; long-term survival rates.

Results: in the long-term period, the overall probability of absence of repeated revascularization in 47 months after PCI was 78,3 ± 2.1% and 72,1 ± 2.4% in the «Nanomed» BLCCC and «MSure Cr» groups, respectively. There was no statistically significant difference between groups (Log. Rank=0,77). However, the incidence of restenosis in the stent was statistically significantly higher in the «MSureCr» group. (p = 0,027). The overall probability of survival in 47 months after surgery was 98,2±2,4% and 98,1±2.6% in groups 1 and 2, respectively. No statistically significant difference between groups was found (Log. Rank=0,4).

Conclusions: 1. The use of a coronary balloon-expandable stent with a BLCCC, Nanomed for endovascular myocardial revascularization is an effective treatment in patients with coronary heart disease.

2. Long-term results of using bioinert carbon-coated stents, Nanomed and MSureCr stents were comparable in terms of absence of myocardial re-revascularization procedures due to relapse of the angina pectoris and survival time of up to 47 months. However, the incidence of restenosis in a stent with a bioinert carbon coating, Nanomed was statistically significantly lower.

 

References

1.     Allender S, Scarborough P, O’Flaherty M, Capewell S. Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline. BMC Public Health 2008, 8, 148.

2.     De Scheerder I, Wang K, Wilczek K et al. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation. 1997; 95: 1549-1553.

3.     Morice M, Urban P, Greene S, Schuler G, Chevalier B. Why are we still using Coronary Bare-Metal Stents? JACC 2013;61;1122-3.

4.     De Mel A, Cousins BG, Seifalian AM. Surface modification of biomaterials: A quest for blood compatibility. Int. J. Biomater. 2012;  707863:1-707863:8.

5.     Kochkina K, Protopopov A. Comparative results of the use of stents with drug and carbon coatings in treatment of patients with all forms of acute coronary syndrome in the long-term follow-up. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2014; 1:52-58 [In Russ].

6.     Carrie D, Lefevre T, Cherradi R, et al. Does Carbofilm coating affect in-stent intimal proliferation? A randomized trial comparing Rx multi-link penta and TecnicCarbostent Stents: SIROCCO Trial. J Interv Cardiol. 2007; 20(5):3818.

7.     De Mel A, Jell G, Stevens MM, Seifalian AM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: A review. Biomacromolecules. 2008; 9: 2969-2979.

8.     Hofma SH, Whelan DM, van Beusekom HM, Verdouw PD, van der Giessen WJ. Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur. Heart J. 1998; 19: 601-609.

9.     Wu KK, Thiagarajan, P. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 1996, 47, 315-331.

10.   Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 2006; 193-202.

11.   Farb A, et al., Pathology of acute and chronic coronary stenting in humans. Circulation. 1999; 99(1): 44-52.

12.   Sarno G, et al., Lower risk of stent thrombosis and restenosis with unrestricted use of 'newgeneration' drug-eluting stents: a report from the nation wide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012;  33(5): 606-13.

13.   Palmerini T, et al., Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;  379(9824): 1393-402.

14.   Antoniucci D, Bartorelli A, Vaenti R, et al. Clinical and angiographic outcome after coronary artery stenting with the Carbostent. Am J Cardiol. 2000; 85: 821-825.

15.   Antoniucci D, Valenti R, Migliorini A, et al. Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure. CathetCardiovasc Interv. 2001; 54: 420-426.

16.   Gian B Danzi, Cinzia Capuano, Marco Sesana et al. Six-Month Clinical and Angiographic Outcomes of the Technic Carbostent(TM) Coronary System: The Phantom IV Study. J Invasive Cardiol. 2004; 16(11): 641-4.

17.   Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: From nearly undamaged to major damaged polymers. Catheter. Cardiovasc. Interv. Off. J. Soc. Cardiac. Angiogr. Interv. 2010; 75: 905-911.

18.   Pendyala L, Jabara R, Robinson K, Chronos N. Passive and active polymer coatings for intracoronary stents: Novel devices to promote arterial healing. J. Interv. Cardiol. 2009; 22: 37-48.

19.   Kesavan S, Strange J, Johnson T et al. First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent. EuroIntervention 2013; 8:1012-1018.

20.   Jung JH, Min PK, Kin JY, Park S, Choi EY, Ko YG, Choi D, Jang Y, Shim WH and Cho SY: Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents? Cardiology. 2005; 104 (2): 72-75,

21.   Kim Y, Whan Lee C, Hong M et al. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial. American Heart Journal. 2005; 149 (2).

22.   George Cesar Ximenes Meireles, Luciano Mauricio de Abreu, Antonio Artur da Cruz Forte et al . Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease. Cardiol. Sro Paulo Apr. 2007; 88 (4).

23.   Ben-Dor I, Waksman R, Pichard A.et al. The Current Role of Bare-Metal Stents. Cardiac interv. 2011; 1:40-45.

24.   Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and metaanalysis. Am Heart J. 2007; 154:221-31.

25.   Bartorelli A, Trabattoni D, Montorsi P Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study. Catheter Cardiovasc Interv. 2002 Feb; 55(2):150-6.

26.   Goods C, Al-Shaibi, Liu M et al. Comparison of aspirin alone versus aspirin plus ticlopidin after coronary artery stenting. Am J Cardiol. 1996; 78:1042-1044.

27.   Leon M, Baim D,Popma J et al. A clinical trial comparing three anthitrombotic drug regimens after coronary artery stentings. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998; 339:1665-1671.

28.   Braun P et al. Prospective randomized study of the restenotic process in small coronary arteries using a Carbofilm coated stent in comparison with plain old balloon angioplasty: a multicenter study. Catheter Cardiovasc Interv. 2007 Dec 1; 70(7):920-7.

29.   Taema K, Moharram A. Long Term Clinical Follow-up of Carbon Coated Stents: Comparative Study with Bare-Metal Stents Med. J. Cairo Univ. 1-8, March: 18, 2014; 82 (2). 

Abstract

Background: in patients with congestive heart failure (CHF), there is a change in indicators of heart mechanics against the background of myocardium remodeling. Currently, magnetic resonance imaging (MRI) and speckle tracking echocardiography provide additional options for assessing changes in heart mechanics. Evaluation of mechanics of the myocardium rotational movement according to coronarography (CAG) has not been found in available literature. In this regard, there is a need to develop a methodology that allows to obtain a mathematical description of rotation processes and heartbeat during the CAG.

Material and methods: study included 90 patients aged 30-71 to assess indicators of heart rotation mechanics. Subjects were divided into groups: with dilated cardiomyopathy (DCMP, n=30), left ventricular aneurysm (LVA, n=30) and patients with autonomic nervous system disorder (ANSD, n=30) without heart failure (control group). Mechanics of heart rotation was studied using the CAG technique, modified by us, based on mathematical calculations of the rotation angle in motion of points on the heart surface, determined on the coronary angiogram in two projections.

Results: study found out, that in patients with DCMP and LVA with chronic heart failure, the angle of rotation of the heart was significantly lower than in patients with ANSD who do not have heart disease (p <0,05). The link between impaired myocardial contractile function in patients with DCMP and LVA with chronic heart failure and a decrease in the heart rotation angle was confirmed (DCMP: ?2=9,774; df=1; P <0,05), (LVA: ?2=9,600; df=1; P <0,05).

Conclusion: coronarography technique that we modified, makes it possible to quantify changes in parameters of the heart mechanics in examined patients. This makes it possible to determine the presence or absence of heart failure, depending on results.

  

References 

1.     Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russian Journal of Cardiology. 2016, 8(136): 7-13 [In Russ].

2.     Belenkov YuN, Mareev VYu. Principles of rational treatment of heart failure.M. 2000. 266 [In Russ].

3.     Popescu BA, Beladan CC, Calin A, et al. Left ventricular remodelling and torsional dynamics in dilated cardiomyopathy: reversed apical rotation as a marker of disease severity. EurJHeartFail. 2009;11(10): 945-51.

4.     Pavlyukova EN, Kuzhel' DA, Matyushin GV, Savchenko EA, Filippova SA. Rotation, twisting and spinning of the left ventricle: physiological role and significance in clinical practice. Regional pharmacotherapy in cardiology. 2015; 11(1): 68-78 [In Russ].

5.     Mondillo S, Galderisi M, Mele D, et al.; Echocardiography Study Group Of The Italian Society Of Cardiology (Rome, Italy). Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med. 2011;30(1):71-83.

6.     Sergio Mondillo, MD, Maurizio Galderis, et al. Speckle-tracking echocardiography - a technique for assessing myocardial function. June 2, 2016. The international online community of specialists in ultrasound diagnostics [In Russ].

7.     Leitman M, Lysyansky P, Sidenko S et al. Two-dimensionalstrain - a novel software for real-time quantitative echocardiographic assessment of myocardial function. J. Am. Soc. Echocardiogr. 2004; 17(10): 1021-1029.

8.     Amundsen BH, Helle-Valle T, Edvardsen T et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol. 2006; 47(4): 789-793.

9.     Buckberg G.D., Weisfeldt M.L., Ballester M. [et al.] Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation. 2004; 110: 333-336.

10.   Mirsky I., Parmley W.W. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ. Res. 1973; 33: 233-243.

11.   Pouleur A., Knappe D., Shah A. [et al.] Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur. Heart J. 2011; 32:1720-29.

12.   Vermes E., Tardif J.C., Bourassa M.G. [et al.] Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials. Circulation. 2003; 931: 2926-2.

13.   Victor Mor-Avi et al. The consensus decision of the American Echocardiographic Society and the European Association of Echocardiography on the methodology and indications, approved by the Japanese Society of Echocardiography. Articles. 07/07/2015 [In Russ].

14.   Roberto M Lang, Michelle Bierig [et al.] Roberto M Lang, Michelle Bierig [et al.]Recommendations for quantifying the structure and chambers of the heart.. Russian Journal of Cardiology 2012; 3(95). This edition of guidelines is published in Eur J Echocardiography 2006; 7: 79-108 [In Russ].

 

Abstract

Heart transplantation (HTx) leads to a marked increase in the duration and quality of life of patients with terminal chronic heart failure. However, in the long-term period, recipients are faced with the problem of cardiac allograft vasculopathy (CAV), which significantly limits the survival of the heart transplant.

Aim: was to assess main approaches to the diagnosis and treatment of cardiac allograft vasculopathy, basing on analysis of literature data on the diagnostic value of invasive methods for assessing the condition of the coronary flow in CAV.

Materials and methods: 43 scientific sources of leading domestic and foreign journals were analyzed.

Results: the review provides data on modern imaging methods in assessing of intimal hyperplasia and neovascularization in patients with a transplanted heart. Possibilities of therapy and prevention of CAV are considered. Information on the role of myocardial revascularization by endovascular and surgical methods in treatment of CAV in various variants of coronary disease is analyzed.

Conclusion: CAV is the main cause of death of recipients in the long term after HTx. A prevention strategy should be based on early diagnosis to identify initial signs of the disease. Endovascular imaging methods are better than others to identify the development of CAV in early stages. Development of methods for the early diagnosis, prevention and treatment of transplant coronary artery disease is one of main tasks of modern transplantology.

  

References 

1.     Gao SZ, Alderman EL, Schroeder JS, Silverman JF. Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12:334-40.

2.     Kazakov Je.N., Kormer A.Ja., Chestuhin V.V., Golubickij V.V. Pathology of coronary arteries of the transplanted heart according to coronary angiography. Transplantologija i iskusstvennye organy, 1996. 4: 74-77 [In Russ].

3.     Tjunjaeva I.Ju. Evaluation of ischemic injury and myocardial revascularization in coronary artery disease of the transplanted heart, Avt. dis. kand. med. nauk. M. 2005; 105 s [In Russ].

4.     Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kuch- eryavaya AY, Levvey BJ, Meiser B, Rossano JW, Chambers DC, Yusen RD, Stehlik J; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017; 36:1037-1046.

5.     Chestukhin V.V., Ostroumov E.N., Tyunyaeva I.Yu., Zakharevich V.M. i dr. Coronary artery disease of the transplanted heart. Diagnostic and treatment options. Ocherki klinicheskoy transplantologii. Pod red. S.V. Gautier. M., 2009.   [In Russ]

6.     M.R. Mehra, M.G. Crespo-Leiro, A. Dipchand, S.M. Ensminger, NE Hiemann, JA Kobashigawa, J Madsen, J Parameshwar, RC Starling, PA Uber. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 29, 717-727 (2010).

7.     AI Dipchand, LB Edwards, AY Kucheryavaya, C Benden, F Dobbels, BJ Levvey, LH Lund, B Meiser, RD Yusen, J Stehlik. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report — 2014; focus theme: retransplantation. J Heart Lung Transplant 33, 985-995 (2014).

8.     Chestuhin V.V., Mironkov A.B., Tjunjaeva I.Ju., Rjadovoj I.G., Zaharevich V.M., Mironkov B.L. Assessment of diastolic dysfunction of the left ventricle of the heart transplant in the development of its vasculopathy. Vestnik transplantologii i iskusstvennyh organov. 2013; 1: 6-11 [In Russ].

9.     Bader FM, Islam N., Mehta N.A., Worthen N. Noninvasive Diagnosis of Cardiac Allograft Rejection Using Echocardiography Indices of Systolic and diastolic Function. J Transplantation Proceedings. 2011; 43: 3877-3881.

10.   Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29:914-56.

11.   Bacal F, Moreira L, Souza G, Rodrigues AC, Fiorelli A, Stolf N et al. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 2004; 23:1238-44.

12.   Rodrigues AC, Bacal F, Medeiros CC, Bocchi E, Sbano J, Morhy SS et al. Noninvasive detection of coronary allograft vasculopathy by myocardial contrast echocardiography. J Am Soc Echocardiogr 2005; 18:116-21.

13.   Sade LE , Eroglu S, Yьce D, Bircan A, Pirat B, Sezgin A, Aydi nalp A, Mьderr isoglu H. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy. J Am Soc Echocardiogr 2014; 27: 531- 539.

14.   Kobashigawa J. Coronary computed tomography angiography: is it time to replace the conventional coronary angiogram in heart transplant patients? J Am Coll Cardiol 2014; 63: 2005-2006.

15.   Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D et al. Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol 2014;63: 1992-2004.

16.   von Ziegler F, Leber AW, Becker A, Kaczmarek I, Schonermarck U, Raps C et al. Detection of significant coronary artery stenosis with 64-slice computed tomography in heart transplant recipients: a comparative study with conventional coronary angiography. Int J Cardiovasc Imaging 2009;25: 91-100.

17.   Pichler P, Loewe C, Roedler S, Syeda B, Stadler A, Aliabadi A et al. Detection of high-grade stenoses with multislice computed tomography in heart transplant patients. J Heart Lung Transplant 2008; 27:310-6.

18.   Rohnean A, Houyel L, Sigal-Cinqualbre A, To NT, Elfassy E, Paul JF. Heart transplant patient outcomes: 5-year mean follow-up by coronary computed tomography angiography. Transplantation 2011; 91: 583-8.

19.   Barthelemy O, Toledano D, Varnous S, Fernandez F Boutekadjirt R, Ricci F et al. Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients. J Heart Lung Transplant 2012; 31: 1262-8.

20.   Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17: 744-53.

21.   Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001; 104: 653-7.

22.   Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol 2001; 87:15A-20A.

23.   Mehra MR, Ventura HO, Stapleton DD, Smart FW. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J Heart Lung Transplant 1995;14(6 Pt 2): S207-11.

24.   Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005;45: 1538-42.

25.   Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005;45: 1532-7.

26.   Stengel SM, Allemann Y, Zimmerli M, Lipp E, Kucher N, Mohacsi P et al. Doppler tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection. Heart 2001;86: 432-7.

27.   Demin V.V., Demin D.V., Seroshtanov E.V., Dolgov S.A., Grigoriev A.V., Demin A.V., Zheludkov A.N., Klochkov M.D., Lomakina E. V. Clinical aspects of the use of optical coherence tomography for the diagnosis of coronary arteries. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2016. №44 С. 42-58. [In Russ]

28.   Francesco Prati, Evelyn Regar, Gary S. Mintz, Eloisa Arbustini, Carlo Di Mario, Ik-Kyung Jang, Takashi Akasaka, Marco Costa, Giulio Guagliumi, Eberhard Grube, Yukio Ozaki, Fausto Pinto, Patrick W.J. Serruys, for the Expert's OCT Review Document; Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis, European Heart Journal, Volume 31, Issue 4, 1 February 2010, Pages 401-415.

29.   Teruhiko Imamura, Koichiro Kinugawa, et al. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness. International Heart Journal, 2014, Volume 55, Issue 2, Pages 178-180.

30.   Yasuhiro Ichibori, Tomohito Ohtani, Daisaku Nakatani, Kouichi Tachibana, Osamu Yamaguchi, Koichi Toda, Takashi Akasaka, Norihide Fukushima, Yoshiki Sawa, Issei Komuro, Junichi Kotani, Yasushi Sakata; Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization, European Heart Journal - Cardiovascular Imaging, Volume 17, Issue 1, 1 January 2016, Pages 51-58.

31.   Kevin C. Harris, Anas Manouzi, Anthony Y Fung, Astrid De Souza, Hiram G. Bezerra, James E. Potts , and Martin C.K. Hosking Feasibility of Optical Coherence Tomography in Children With Kawasaki Disease and Pediatric Heart Transplant Recipients / Originally published - 29 May 2014 - Circulation: Cardiovascular Imaging. 2014;7: 671-678.

32.   S.A. Sahovskij, N.N. Koloskova, A.Ju. Goncharova, B.L. Mironkov. Intravascular Imaging Techniques in Assessing Transplanted Heart Vasculopathy. Vestnik transplantologii i iskusstvennyh organov. 2019; 1: 165-168. [In Russ].

33.   Muehling OM, Wilke NM, Panse P, Jerosch-Herold M, Wilson BV , Wilson RF, Miller LW . Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003; 42: 10541060.

34.   Braggion-Santos MF, Lossnitzer D, Buss S, Lehrke S, Doesch A, Giannitsis E, Korosoglou G, Katus HA , Steen

H.    Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy. Eur Heart J Cardiovasc Imaging 2015; 15: 1125-1132.

35.   Johnson MR, Aaronson KD, Canter CE, et al. Heart retransplantation. Am J Transplant 2007; 7: 2075-81.

36.   Klauss V, Spes CH, Rieber J, Siebert U,Werner F Stempfle HU et al. Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease. Transplantation 1999;68: 1477-81.

37.   Raichlin E, Prasad A, Kremers WK, et al. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J 2009; 30:1356-63.

38.   Arora S, Ueland T, Wennerblom B, et al. Effect of everolimus introduction on cardiac allograft vasculopathy-results of a randomized, multicenter trial. Transplantation 2011;92: 235-43.

39.   Arora S, Andreassen AK, Andersson B, et al., SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidanc E) Investigators. The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial. Am J Transplant 2015; 15: 1967-75.

40.   Richard Cheng, Evan Kransdorf, David Chang, Jig- nesh Patel, Jon Kobashigawa and Babak Azarbal TCT-401 A Strategy of Percutaneous Coronary Intervention with Drug-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy May Normalize Survival (2018).

41.   Lee MS, Cheng RK, Kandzari DE, et al. Longterm outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention. Am J Cardiol 2012; 109: 1729-32.

42.   Jay K. Bhama, Duc Q. Nguyen, Sun Scolieri, Jeffrey J. Teuteberg, Yoshiya Toyoda, Robert L. Kormos, Kenneth R. McCurry, Dennis McNamara, Christian A. Bermudez, Surgical revascularization for cardiac allograft vasculopathy: Is it still an option? The Journal of Thoracic and Cardiovascular Surgery, Volume 137, Issue 6, 2009, Pages 14881492.

43.   Ilke Sipahi, Randall C. Starling Cardiac Allograft Vasculopathy: An Update Heart Failure Clinics Volume 3, 2007; 1: 87-95.

 

Abstract:

Background: article presents a case of 11-month-old baby weighing 6,590, with phenomena of circulatory decompensation, and non-standard hybrid intervention using retroperitoneal open access to the infrarenal aorta - stent implantation with the potential for increasing its diameter as the child grows

Materials and methods: the patient underwent examination - echocardiography (Echo-CG), multispiral computed tomography (MSCT), angiography Indication for the operation was the restenosis of the distal aortic anastomosis after the stage-by-stage surgical correction of hypoplastic left heart syndrome (Norwood procedure). This tactic was chosen taking into account the extremely high risk of re-surgery, as well as the impossibility of stent implantation with the potential for increasing the diameter through access to the femoral artery (body weight of the child is 6.6 kg). The patient underwent stenting of restenosis of the distal aortic anastomosis through retroperitoneal open access to the infrarenal aorta.

Results: good early postoperative period, against the background of disaggregant therapy (aspirin 5 mg/kg per day) and antibiotic therapy In control echocardiography (Echo-CG), the systolic pressure gradient in the stent implantation zone is 22 mm hg. The patient was discharged to an outpatient stage, followed by examination after 6 months and possible re-intervention (stent dilatation with a larger diameter balloon) as the pressure gradient rises as the child grows. Proposed hybrid approach in a child 11 months with a body weight of 6,590 kg allowed to avoid the risk of re-surgery in conditions of circulatory arrest and demonstrated a satisfactory angiographic and clinical result.

Conclusion: stenting of restenosis in distal aortic anastomosis using retroperitoneal access can be considered as a surgery of choice in specialized centers.

 

References

1.      Sakurai T., Rogers V., Stickley J. et. al. Single-center experience of arch reconstruction in the setting of Norwood operation. Ann.Thorac. Surg. 2012; 94:1534-1539.

2.      Pavlichev G.V., Podoksenov A.YU., Krivoshchekov E.V. Obstruction of the aortic artery after Norwood surgery in children with hypoplastic left heart syndrome. Patologiya krovoobrashcheniya i kardiohirurgiya. 2014;18(2):13-16 [In Russ].

3.      Bartram U., Granenfelder J., Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Eur. Vasc. Endovasc. Surg. 2017; 53(5):617-625.

4.      Vitanova K., Cleuziou J., Pabst von Ohain J. et. al. Recoarctation After Norwood I Procedure for Hypoplastic Left Heart Syndrome: Impact of Patch Material. Ann. Thorac. Surg. 2017; 103(2):617-621.

5.      Thomas P, Doyle M.D., William E. et al.Aortic obstructions in infants and children. Progress in Pediatric Cardiology. 1994; 3(1): 37-44.

6.      Rothman A., Galindo A., Evans W.N. et. al. Effectiveness and safety of balloon dilation of native aortic coarctation in premature neonates weighing <or = 2,500 grams. Am. Cardiol. 2010; 105:1176- 80.

7.      Atalay A., Pac A., Avci T.et. al. Histopathological evaluation of aortic coarctation after conventional balloon angioplasty in neonates. Cardiol. Young. 2018; 18:1-5.

8.      Dijkema E.J., Sieswerda G.T., Takken T.et. al. Longterm results of balloon angioplasty for native coarctation of the aorta in childhood in comparison with surgery. Eur. Cardiothorac. Surg. 2018 1; 53(1): 262-268.

9.      Fiore A.C., Ficher L.K., Schwartz T. et. al. Comparison of angioplasty and Surgery for Neonatal Aortic Coarctation. The society of the thoracic surgeons. 2005; 80:1659-65.

10.    Shaddy R., Boucek M., Sturtevant J., et.al. Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation.1993; 87:793-9.

11.    Attia I.M., Lababidi Z.A. Transumbilicalballon coarctation angioplasty. Am. Heart. 1988; 166:1623-4.

12.    Redington A.N., Booth P, Shore D.F., Rigby M.L., Primary ballon dilatation of coarctation of aorta. A multi-institutional study. Thor. Cardiovasc. Surg. 1994;108:841-51.

13.    Richard E.R., Gauvreau K., Moses H., et.al. Coarctation of the Aorta Stent Trial (COAST): Study design and rationale. Am. Heart. 2012; 164 (1): 7-13.

14.    Coulson J.D.,Vricella L.A., Alekyan B.G. Аlternative arterial and venous access for catheterization in children and infants. Endovaskulyarnaya hirurgiya. 2016;4: 24-39 [In Russ].

15.    Pursanov M.G., Svobodov A.A., Levchenko E.G. et. al. New Approach for Hybrid Stenting of the Aortic Arch in Low Weight Children. Structural Heart Disease. 2017;(3)5:147-151.

16.    Dorfer C., Standhardt H., Gruber A., et. al. Direct Percutaneous Puncture Approach versus Surgical Cutdiwon Technique for Intracranial Neuroendovascular Procedures: Technical Aspects. World Neurosur. 2012; 77(1): 192-200.

17.    Chakrabati S., Kenny D., Morgan G. et. al. Balloon expandable stent implantation for native and recurrent coarctation of the aorta - prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010; 96 (15): 1212-6.

18.    Davenport J.J., Lam L., Whalen-Glass R., et. al. The successful use of alternative routes of vascular access for performing pediatric interventional cardiac catheterization. Cathet. Cardiovasc. Interv. 2008; 72 (3): 392-8.

19.    Sivanandam, S., Mackey-Bojack S.M., Moller J.H. Pathology of the aortic arch in hypoplastic left heart syndrome: surgical implications. PediatrCardiol. 2011; 32: 189-192.

20.    Hammel J.M., Duncan K.F., Danford D.A. et.al. Two- stage biventricular rehabilitation for critical aortic stenosis with severe left ventricular dysfunction. Eur. Cardiothorac. Surg. 2012; 1-6.

21.    Alekyan B.G. X-ray endovascular surgery. National Guidelines. M: Litterra. 2017; 1: 247-262 [In Russ].

22.    Feltes T.F., Bacha E., Beekman R.H. et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease. А scientific statement from the Am. Heart Association. Circulation. 2011: 7;123(22): 2607-52.

 

Abstract:

Technological advance in multislice computed tomography (MSCT) set the radiologists all over the world thinking of its application in patients with ischemic heart disease. Proved diagnostic efficiency of 64-slice MSCT coronary angiography nominates the technique to be a first-line screening method for coronary atherosclerosis: it allows quick, accurate, and non-invasive imaging and quantitative assessment of coronary lesions. Though the indications for MSCT has already defined, there still are contro-versies about its place in diagnostic strategy. The aim of our study was to picture the state-of-the-art MSCT capabilities, focusing on MSCT coronary angiography and its place in contemporary clinical medicine.

 

Reference

1.     Achenbach S. et. al. Top 10 indications forcoronary СТА. Supplement to Applied Radiology.2006; 35 (12): 22-31.

2.     Gaspar T., Halon R., Rubinshtein N. Clinicalapplications and future trends in cardiacСТА. Eur. Radiol. Suppl. 2005; 15 (l4): 10-14.

3.     Jacobs J.E. How to perform coronaryСТА: A to Z, Supplement to Applied Radiology.2006; 12: 10-17.

4.     Синицын В.Е., Воронов Д.А., Морозов С.П.Степень кальциноза коронарных артерийкак прогностический фактор осложнений сердечно-сосудистых заболеваний без клинических проявлений: результаты метаанализа. Терапевтический архив. 2006; 9: 22-27.

5.     Терновой С.К., Синицын В.Е., Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М: Атмосфера. 2003; 144.

6.     Синицын В.Е., Устюжанин Д.В. КТ-ангиография коронарных артерий. Кардиология. 2006; 1: 20-25.

7.     Ehara M., Surmely J.F., Kawai M. et al.Diagnostic accuracy of 64-slice computedtomography for detecting angiographicallysignificant coronary artery stenosis in an unselected consecutive patient population:Comparison with conventional invasiveangiography. Circ.J. 2006; 70: 564-571.

8.     Leschka S. et al. Accuracy of MSCT coronaryangiography with 64-slice technology: firstexperience. Eur. Heart. J. 2005; 26: 1482-1487.

9.     Wann S. Cardiac CT for risk stratification,Supplement to Applied. Radiology. 2006; 12: 41-44.

10.   Hoffmann U., Moelewski F., Cury R.C. et al.Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease 17.in patients at high risk for coronary artery disease. Patient-versus segment-based analysis. Circulation. 2004; 110: 2638-2643.

11.   Rienmuller R., Brekke O., Kampenes V.B. et al. Dimeric versus monomeric nonionic contrast agents in visualization of coronary arteries. Eur.J. Radiol. 2001; 38 (3): 173-178.

12.   Dewey M. et al. Head-to head comparison of multislice computed tomography angiography and exercise electrocardiography for diagnosis of coronary artery disease. Eur. Heart. 2007; 10, 28 (20): 2485-2490.

13.   Schlosser T., Konorza T., Hunold P. et al. Noninvasive visualization of coronary artery bypass grafts using 16-detector row computed tomography. JACC. 2004; 44: 1224-1229.

14.   Chabbert V., Carrie D., Bennaceur M. et al. Evaluation of in-stent restenosis in proximal coronary arteries with multidetector computed tomography (MDCT). Eur Radiol. 2007; 17: 1452-1463.

15.   Schijf J.D., Bax J.J., Jukema J.W. et al. Feasibility of assessment of coronary stent patency using 16-slice computed tomography. Am.J. Cardiol. 2004; 94: 427-430.

16.   Mahnken A.H., Buecker A., WildbergerJ.E. et al. Coronary artery stents in multislice computed tomography: in vitro artefact evaluation. Invest Radiol. 2003; 39: 27-33.

17.   Cademartiri F., Marano R., Runza G. et al. Non-invasive assessment of coronary stent patency with multislice CT: preliminary experience. Radiol. Med. (Torino). 2005; 109 (5-6): 500-507.

 

Abstract:

To evaluate the extent and distribution of focal fibrosis by delayed contrast-enhanced magnetic resonance imaging (DCE MRI) in patients with severe left ventricle hypertrophy caused by genetically determined hypertrophy cardiomyopathy (HCP) and compare it with global and regional myocardial function. 15 patients with HCP were studied using 1,5 T MR-scanner (Avanto, Siemens Medical Solution). 80% patients with HCP had foci of delayed CE, which were predominantly located in the anteroseptal. 33% patients with HCP had foci of perfusion defects. Septal walls with DCE foci were significantly thicker than non-enhanced segments (19,0±6,4 and 10,6±4,7, p < 0,001). Significant correlations were observed between end-diastolic segment's thickness and extent of DCE (r = 0,26, p < 0,05). Significant reverse correlation was found between extent of contrast enhancement and stroke volume in patients with HCP (r = -0,57, r < 0,05). Mean volume DCE regions was 18,4±8,5 cm3 (Mean±SE), maximum volume of hyperenhanced area was 127,9 cm3. Abnormal signal intensity from first-pass myocardial perfusion correlates with the delayed enhancement foci in patients with HCM. The extent of focal scarring in patients with HCP may reflect the severity of myocardial damage associated with the regional hypertrophy and hypokinesia of these segments.

 

Reference 

 

1.     Report of the 1995 WHO/IFSC. Task force of the definition and classification of cardiomyopathies. Circulation. 1996; 93: 841-889.

 

 

2.     Elliott P., Sharma S. et al. Survival agter cardiac arrestor sustained ventricular tachycardia in ptc with hypertrophic cardiomyopathy. JACC. 1999; 33: 1596-1601.

 

 

3.     Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA. 2002; 287: 1308-1320.

 

 

4.     Maron B.J. Hypertrophic cardiomyopathy and suddendeath: new perspectives on risk stratification and prevention with implantable cardioverter-defibrillator. Eur.Heart.J. 2000; 201: 1979-1983.

 

 

5.     Maron B.J., Epstein S.E., Roberts Wc. Hypertrophic cardiomyopathy and transmural myocardial infarction without signicant atherosclerosis of the extramural coronary arteries. Am. J. Cardiol. 1979; 43: 1086-1102.

 

 

6.     Tanaka M., Fujiwara H., Onodera E. et al. Quantitative analysis of myocardioal fibrosis in normal, hypertensive hearts and hypertrophic cardiomyopathy. Br.Heart. J. 1986; 55: 575-581.

 

 

7.     Rickers K., Wilke N., Jerosh-Herold M. et al. Utiliye of magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005; 112:855-861.

 

 

8.     Gupta A., Lee V.S., Chung Y.C. et al. Myocardial in arction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004;   233:1001-1004.

 

 

9.     Kuhl H.P., Papavasiliu T.S., Beek A.M. et al. Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion-recovery prepared pulse sequence. Radiology. 2004; 230:576-582.

 

 

10.   Moon J., Reed E., Sheppard M. et al.The histologic basis of late enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.JACC. 2 004; 43: 2260-2264.

 

 

11.   Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов. М.: Видар. 1998.

 

 

12.   Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B.,Wu E., Bundy J.M., Finn J.P., Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-223.

 

 

13.   Cerqueira M.D., Weissman N.J., Dilsizian V. et al. Standardised myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105: 539-542.

 

 

14.   Choudhury L., Mahrholdt H., Wagner A., Choi K.M.,Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., Kim R J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J.Am. Coll. Cardiol. 2002; 40: 2156-2164.

 

 

15.   Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M.,Smith G.C., Pennell D J.Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2003; 41: 1561-1567.

 

 

16.   Debl K., Djavidani B., Buchner S., Lipke C., Nitz W., Feuerbach S., Riegger G., Luchner A. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006; 92: 1447-1451.

 

17.   Dumont C.A., Monserrat L., Soler R., Rodriguez E.,Fernandez X., Peteiro J., Bouzas B., Pinon P., Castro-Beiras A. Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance inpatients with hypertrophic cardiomyopathy. Rev. Esp.Cardiol. 2007; 60: 15-23.

Abstract:

At 246 patients with coarctation of the aorta the ultrasonic semiotics of disease has been investigated. Are systematized echocardiographycal attributes of defect: are determined direct and indirect (displays directly reflecting morphology), the estimation of their sensitivity and specificity is lead. The certain combination of the specified attributes has allowed to allocate three variants of a ultrasonic picture coarctation of the Aorta, reflecting various anatomic forms of defect. The semiotics and diagnostic attributes of each ultrasonic variant of defect is described by echocardiography. 

 

 

Reference 

 

1.     Шиллер Н., Осипов М. А. Клиническая эхокардиография. М. 1993.

2.     Митьков В. В., Сандриков В. А. Клиническое руководство по ультразвуковой диагностике в 5 т. М.: Видар. 1998; 5: 96-297.

3.     Бураковский В. И., Бокерия Л. А. Сердечно-сосудистая  хирургия   (руководство).   М.:   Медицина.1989; 298-310.

4.     Kaine S. E, Smith E. О., Mott A. R. et al. Quantitative echocardiographic analysis of the aortic arch predicts outcome of balloon angioplasty of native coarctation of the aorta. Circulation. 1996;   94 (5): 1056-1062.

5.     Фейгенбаум X. Ультразвуковая диагностика. М.: Медицина. 1999; 1123-1145.

 

 

Abstract:

Lesions of the LCA stem are found in 2,5-4 % of patients with coronary heart disease who endured coronography, and are accompanied by more severe symptomatology, higher morbidity and mortality rates, and difficulty of radical correction. According to the generally accepted guidelines, the operation of coronary artery bypass has up to now been a method of choice in treatment of the LCA stem. Nevertheless, endovascular methods of treatment for LCA stem lesions have relatively long been used, while implementation into clinical practice of drug-eluding stents has considerably improved the remote outcomes, which made it possible to consider LCA stem stenting as a real alternative to ACB. Hence, the problem concerning indications for and contraindications to LCA stem stenting remains unsolved today. We retrospectively analysed a total of 75 endovascular interventions on the LCA stem in 67 patients, with an isolated lesion of the LCA stem being found only in 7,4 % of the patients. The remaining subjects had lesions of the LCA stem on the background of a multivascular lesion of the coronary bed, including occlusion of the RCA observed in 16,4 % of cases. Successive revascularization was performed in 98,64 % of cases, with no lethal outcomes. One patient required urgent ACB due to development of occluding dissection of the circumflex branch. Complications in the immediate postoperative period were observed in two patients and were represented by non-Q myocardial infarction and stroke. LCA stem stenting proved an efficient and safe method of treatment for coronary heart disease. A comparative analysis of the immediate results of LCA stem stenting and ACB revealed advantages of stenting, consisting in no lethal outcomes (in our series) and a lower short-term rate of postoperative complications.

  

Reference

1.     Cohen МУ Cohn PF, Herman MV, Gorlin R. Diagnosis and prognosis of main left coronary artery obstructtion. Circulation 1972; 45 (Suppl 1): 57 - 65.

2.     Gruentzig A.R. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263.

3.     O'Keefe JH, Harztler GO, Rutherford BD, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am. J. Cardiol. 1989; 64: 144 - 147.

4.     Seung-Jung Park, MD, PHD, Young-Hak Kim, MD, Bong-Ki Lee, MD et al. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis Comparison With Bare Metal Stent Implantation. Journal of the American College of Cardiology. 2005; 3 (45): 351-6.

5.     Seung-Jung Park, Young-Hak Kim, Bong-Ki Lee, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Gary S. Mintz, MD, Seong-Wook Park. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis. J. Am. Coll. Cardiol. 2005; 45: 351-6.

6.     Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004; 109: 1244-9.

7.     Arampatzis CA, Hoye A, Saia F, et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome. Cathet. Cardiovasc. Interv. 2004; 62: 292 - 6.

8.     Joseph P. Ornato, Richard L. Page, Barbara Riegel etal. A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary. Circulation. 2006; 113: 156 - 175.

9.     Caracciolo EA, Davis KB, Sopko G, Kaiser GC et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: Long-term CASS experience. Circulation. 1995; 91: 2335-44.

10.   Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994; 344: 563 - 570.

11.   Park S, Hong M, Lee CW, et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J. Am. Coll. Cardiol. 2001; 38: 1054 - 1060.

12.   TakagiT, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos У Liis-tro F, Briguori C, Corvaja N, Albero R, Sivieri G, Paloschi R, Di Mario C, Colombo A. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002; 106: 698 - 702.

13.   Sorin J. Brener, MD; Bruce W Lytle, MD; Ivan P. Casserly, MD; Jakob P. Schneider, RN; Eric J. Topol, MD; Michael S. Lauer, MD. Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation. 2004; 109: 2290 -2295.

14.   Silvestri M, LefПvre T, Labrunie P, Khalife K, Bayet G, Morice MC, Bedossa M, Chmait A.. On behalf of the FLM registry investigators. The French registry of left main coronary artery treatment: Preliminary results. J. Am. Coll. Cardiol. 2003; 41: 45.

15.   Brigouri C, Sarais C, Pagnotta P, Airoldi F, et al. Elective versus provisional pumping in high-risk percutaneus transluminal coronary angioplasty. Am. Heart J. 2003; 145 (4): 700 - 7.

16.   Бокерия Л. А., Алекян Б. Г., Бузиашвили Ю. И. и др

 

 

Abstract:

Endovascular methods of treatment for coronary heart disease are of considerable current use. Stenting of coronary arteries is the most widely used intervention in management of coronary heart disease. Present-day models of coronary stents make it possible to selectively perform direct stenting in certain roentgenomorphology of the lesion concerned. The authors analysed the outcomes of direct and conventional stenting of coronary arteries in 74 patients presenting with coronary heart disease. No differences as to the mortality rate were observed between the groups. The group of direct stenting demonstrated lower percentage of ischemic events: myocardial infarction on the background of acute or subacute thrombosis of the stent (1 - in the direct-stenting group, 3 - in the conventional-stenting group), transitory myocardial ischaemia (1 case in the direct-stenting group, 3 cases in the conventional-stenting group). Of the angiographic peculiarities, dissection complicated a total of three procedures of traditional stenting, and did not occur in the direct-stenting group. The no-reflow syndrome was noted to have developed in one case in the stenting group with predilatation. Of the technical peculiarities in the direct-stenting group, we observed a statistically reliable decrease in the average duration of the intervention by 11,76 minutes (P = 0,039), that of roentgenoscopy by 5,91 minutes (P = 0,027), a decrease in the average consumption of the radiopaque medium by 68,36 ml (P < 0,01), and a decrease in the average expenditure of coronary balloon catheters by 0,59 pc. (P < 0,001). Hence, the method of direct stenting of coronary arteries turned out to offer advantages over the conventional-stenting technique with predilatation in the clinical, angiographic and economic aspects, provided a careful selection of patients is performed.

  

Reference

1.     Фуфаев Е.Н. К вопросу о методике клинико-социальных исследований по изучению потребности в кардиохирургической помощи. Качественная Клиническая Практика. 2003; (31) 2: 13-108.

2.     Бокерия Л.А., Гудкова Р.М. Сердечно-сосудистая хирургия - 2004. Болезни и врожденные аномалии системы кровообращения. М., НЦССХ им. А.Н. Бакулева РАМН. 2005; 118.

3.     Rogers С, Parikh S., Seifert P. Edelman E. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation. 1996; (94).2909-2914.

4.     Villegas B., Morice M.C., Hernandez S. et al. Triple Vessel Stenting for Triple Vessel Coronary Disease. The Journal of Invasive Cardiology. 2002; (14): 1-5.

5.     Chauhan A., Vu E., Ricci D.R., et al. Early and intermediate term clinical outcome after multiple coronary stenting. Heart. 1998; (79): 29-33.

6.     Kastrati A., Hall D., SchЪmig A. Long-term outcome after coronary stenting. Curr. Control Trials Cardiovasc Med. 2000; (1): 48-54.

7.     La Manna A., Di Mario C. Therapeutic Strategies in Multiple Vessel Coronary Artery Disease. E-Journal of European Society of Cardiology. 2005; (29): 17-23.

8.     Triantis G.S., Tolis V.A., Michalis L.K. Direct Implantation of Intracoronary Stents. Hellenic J. Cardiol. 2002; (43): 156-160.

9.     Weaver W.D., Reisman M.A., Griffin J.J., et al., for the OPUS-1 Investigators. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet. 2000; (355): 203-219.

10.   Schuhlen H., Kastrati A., Dirschinger J. Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First Month. Circulation. 1998; (98): 104-111.

 

Abstract:

We performed the analysis of published data on the use of multislice computed tomography in diagnostics of coronary heart disease. The data on the development of the method, indicated that it its diagnostic efficiency is related to technological improvements, accompanied by the appearance of each successive generation of multislice computed tomography We described possibilities of using of scanners from 16 to 230-slice, devices with two sources of energy, advantages of «dual energy» regime application in the coronary disease diagnostics. Given constraints on the method diagnostic efficacy - artifacts associated with the movement and severe calcification. It is indicated that the implementation of the method in cardiology practice promotes its consideration as a promising alternative to invasive diagnostic coronary angiography, it is suggested becoming of further development of the technology that will allow multislice computed tomography to become the main method of diagnosis of coronary heart disease and other cardiovascular diseases.  

 

References 

1.    Paul J.F., Dambrin G., Caussin C. et al. Sixteen-slice computed tomography after acute myocardial infarction: from perfusion defect to the culprit lesion. Circulation. 2003; 108: 373-374.

2.    Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

3.    Costello P., Lobree S. Subsecond scanning makes CT even faster. Diag. Imaging. 1996; 18: 76-79.

4.    Taguchi K., Aradate H. Algorithm for image reconstruction in multi-slice helical CT. Med. Phys. 1998; 25: 550-561.

5.    Flohr T.G., Schaller S., Stierstorfer K. et al. Multidetector row CT systems and image-reconstruction techniques. Radiology. 2005; 235: 756-773.

6.    Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography? Am. Heart J. 2005; 149: 1112-1119.

7.    Goldman L.W. Principles of CT: multislice CT. J. Nucl. Med. Technol. 2008; 36: 57-68.

8.    Lewis M., Keat N., Edyvean S. 16 Slice CT scanner comparison report version 14, 2006. Available from: URL: http://www.impactscan.org/reports/Report06012.htm

9.    Achenbach S., Ropers D., Pohle F.K. et al. Detection of coronary artery stenoses using multi-detector CT with 16x0.75 collimation and 375 ms rotation. Eur. Heart J. 2005; 26: 1978-1986.

10.  Kuettner A., Beck T., Drosch T. et al. Image quality and diagnostic accuracy of non-invasive coronary imaging with 16 detector slice spiral computed tomography with 188 ms temporal resolution. Heart. 2005; 91: 938-941.

11.  Garcia M.J., Lessick J., Hoffmann M.H. Accuracy of 16-row mul-tidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006; 296: 403-411.

12.  Flohr T.G., McCollough C.H., Bruder H. et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 2006; 16: 256-268.

13.  Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

14.  Achenbach S., Marwan M., Schepis T. et al. High- pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

15.  Ruzsics B., Lee H., Zwerner P. et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur. J. Radiol. 2008; 18: 2414-2424.

16.  Jiang H.C., Vartuli J., Vess C. Gemstone-the ultimatum scintillator for computed tomography. Gemstone detector white paper. London: GEHealthcare. 2008: 1-8.

17.  Sun Z., Jiang W. Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur. J. Radiol. 2006; 60: 279-286.

18.  Pontone G., Andreini D., Bartorelli A. et al. Diagnostic accuracy of coronary computed tomography angiography: a comparison between prospective and retrospective electrocardiogram triggering. J. Am. Coll. Cardiol. 2009; 54: 346-355.

19.  Sun Z., Ng K.H. Diagnostic value of coronary CT angiography with prospective ECG-gating in the diagnosis of coronary artery disease: a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging. 2012; 28: 2109-2119.

20.  Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

21.  Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl. J. Med. 2008; 359: 2324-2336.

22.  Alkadhi H., Stolzmann P., Desbiolles L. et al. Low-dose, 128-slice, dual-source CT coronary angiography: accuracy and radiation dose of the high-pitch and the step-and-shoot mode. Heart. 2010; 96: 933-938.

23.  Hou Y, Yue Y, Guo W. et al. Prospectively versus retrospectively ECG-gated 256-slice coronary CT angiography: image quality a

 

Abstract:

Stenting of the patent ductus arteriosus (PDA) is a relatively new method of palliative treatment ir children with congenital heart disease (CHD) and is an alternative to systemic-pulmonary shunt.

Aim: was to evaluate the efficacy of stenting in the PDA as a palliative care in children with pulmonary ductus-dependent hemodynamic in «Children Repubfcan Clinical Hospital» (CRCH).

Materials and methods: we analyzed data of 11 patients, with CHD and pulmonary ductus-dependent hemodynamics, who underwent stenting of PDA in CRCH for the period of 2007-2015. To assess the effectiveness of the procedure we took into consideration following data: clinical diagnosis; patient's condition before and after stenting of PDA.

Results: primary stenting of PDA was success in 10 patients, there was no severe complication and death. In 1 patient, there was a stent migration to the pulmonary artery, and due to the closure of the PDA and thus increasing cardiovascular insufficiency, child was taken to the corrective surgery, during which the stent was removed. As a result, in 10 successfully stented patients, in nearest follow-up observation period (15 to 28 days, mean 22 days), 7(70%) patients had a positive effect; in 3 patients progressing hypotension appeared on the 2nd day after the treatment, that leaded to pefrorming of endovascular procedures with Rashkind's method. In the later follow-up observation period, 6 of 7 patients had remaining satisfactory parameters of pulmonary hemodynamics (saturation ranged from 78% to 92%), before using of radical correction of pathology (in terms of 3 to 6 months.).

Conclusion: the stenting procedure for closing of PDA as a palliative treatment for infants with CHD and pulmonary ductus-dependent hemodynamics is effective to stabilize the severe clinical condition of patients prior to radical correction of defects in 60% of cases.  

 

References 

1.    Denise van der Linde, Elisabeth E.M. Konings, Maarten A. Slager, at al. Prevalence of Congenital Heart Disease Worldwide : A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology. 2011; 58(21): 2241-2247.

2.    Emelyanchik E.Y., Kirilova Y.P., Yakshanova S.V., et al. Rezultaty primeneniya preparata prostoglandina E1 Vazaprostana v lechenii detey s duktus-zavisimym krovoobrascheniem. [Results of drug prostaglandin E1 Vazaprostan in treatment of children with ductus-dependent hemodynamics]. Sibirskoe meditsinskoe obozrenie. 2013; 6: 68-72. [In Russ].

3.    Mirolubov L.M. Vrozhdyennye poroki serdtsa u novorojdennykh I detey pervogo goda zhizni. [Congenital heart defects in newborns and infants]. Kazan. 2008: 33-51. [In Russ]

4.    Vakhvalova I.V., Idov Е.М., Shirogorova A.V.,et al. Duktus- zavisimye vrozhdennye poroki razvitiya serdtsa u detey: osobennosti klinicheskogo techeniya na etapakh do- i posleoperatsionnogo vykhazhivaniya. [Ductus-dependent congenital heart disease in children: clinical features at stages of pre- and postoperative nursing.] Vestnik uralskoy meditsynskoy akademicheskoy nauki. 2008; 2: 47-52. [In Russ]

5.    Bokeriya L.A., Alekyan B.G. Rukovodstvo po rentgenendovaskulyarnoy hirurgii serdtsa I sosudov. [Guidelines for endovascular surgery of the heart and blood vessels. The 3 volumes.] Т 2. Moskow. 2013; 289-303. [In Russ].

6.    Berishvili I.I., Garibyan V.A., Aleksii-Meskhishvili V.V., et al. Priobretyennaya deformastiya legochnoy arterii posle nalozheniya mezharterialnogo anastomoza u detey rannego vozrasta. [Acquired deformity of the pulmonary artery anastomosis after the imposition between arterial in infants]. Grudnaya khirurgiya. 1978; 5: 51-56. [In Russ]

Multivessel coronary disease: endovascular palliation in cto patients



DOI: https://doi.org/10.25512/DIR.2009.03.2.05

For quoting:
Shakhov B.E., Sharabrin E.G., Shakhov E.B., Blinov P.A., Shakhova E.B., Chebotar E.V. "Multivessel coronary disease: endovascular palliation in cto patients ". Journal Diagnostic & interventional radiology. 2009; 3(2); 39-45.

 

Abstract:

Purpose. To assess the effectiveness of palliative endovascular interventions in patients with CTO anatomy infavorable for recanalisation.

Material and methods. The authors analyzed the results of interventions in 60 patients (50 male (83,3%), 10 female (16,7%)) aged 38 – 75 years (mean age 53,9±3,2), with occlusive coronary disease. Palliative revascularizations were performed in 30 patients, and CTO recanalization was done in 30 cases. The LV function was assessed echocardiographically in both groups before and after the intervention.

Results. 12 month follow-up showed significant improvement or normalization of LV function in both groups. Results of palliative interventions were shown to be as effective as recanalization of CTO.

Conclusions. Endovascular palliation is effective in treatment of patients with coronary CTO. It results in myocardial function improvement comparable to that in patients with complete coronary revascularization.   

 

References

1.        Danchin N., Angioi M., Rodriguez R. Angioplasty in chronic coronary occlusion. Arch. Mal. Coeur Vaiss. 1999, 99 (11): 1657–1660.

2.        Meier B. Chronic total coronary acclusion angioplasty. Cathet Cardiovasc. Diagn, 2006; 25: 1–11.

3.        Ганюков В.И., Осиев А.Г. Частные вопросы коронарной ангиопластики. Новосибирск. 2002; 4–23.

4.        Лопотовский П.Ю., Яницкая М.В. Клинический эффект эндоваскулярной реперфузии миокарда в бассейне длительно окклюзированной коронарной артерии. Между народный журнал интервенционной кардиоангиологии. 2006; 10: 22–26.

5.        Султан М.В. Реваскуляризация миокарда при остром коронарном синдроме. Авто-реф. дис. канд. мед. наук. М. 2006: 15–20.  

6.        Иоселиани Д.Г., Громов Д.Г., Сухоруков О.Е., Хоткевич Е.Ю., Семитко С.П., Исаева И.В., Верне Ж.-Ш., Арабаджян И.С., Овесян З.Р., Алигишева З.А. Хирургическая и эндоваскулярная реваскуляризация миокарда у больных с многососудистым поражением венечного русла: сравнительный анализ ближайших и среднеотдаленных результатов. Международный журнал интервенционной кардиоангиологии. 2008; 15: 22–31.

7.        Араблинский А.В. Степень реваскуляризации миокарда с помощью транслюминальной баллонной ангиопластики у больных с многососудистым поражением коронарного русла. Международный медицинский журнал. 2000; 1: 2–6.

8.        Ott R.A., Tobis J.M., Mills T.C., Allen B.J., Dwyer M.L. ECMO assisted angioplasty for cardiomyopathy patients with unstable angina. Department of Cardiothoracic Surgery, University of California. Irvine Medical Center. 2006.  

9.        Gaudino M., Santarelli P., Bruno P., Piancone F.L., Possati G. Palliative coronary artery surgery in patients with severe noncardiac diseases. Department of Cardiac Surgery, Catholic University. Rome. Italy. 2006.  

10.      Гринхальх Т. Основы доказательной медицины. Учебное пособие. М. 2004; 58.  

11.      Петросян Ю.С., Иоселиани Д.Г. О суммарной оценке состояния коронарного русла у больных ишемической болезнью сердца. Кардиология. 1976; 12 (16): 41–46.

12.      Петросян Ю.С., Шахов Б.Е. Коронарное русло у больных с постинфарктной аневризмой левого желудочка сердца. Горький. 1983; 17–37.

 

 

13.      Rahimtoola S.H. The hibernating myocardium. Ibid. 1989; 117: 211–221.

 

 

Abstract:

Aim: was to investigate possibilities of multislice computed tomography in estimation of stenosis degree in coronary arteries in patients with ischemic heart disease (IHD).

Materials and methods: we examined 64 patients (18 female, 46 male, mean age 62,4± 9,5 years), who primary had been admitted to hospital and had high risk of IHD; and those who had early diagnosed IHD of 1,2,3 and 4 functional class, they were hospitalized for condition correction. Mainly spreaded risk factor was arterial hypertention in 55 patients - (85,9%) with highest level 200/100 mm hg and minimal 140/80 mm hg. All patients underwent multislice computed tomography (MSCT) on the 256-slice tomography station «Somatom definition flash (Siemens, Germany)»: collimation 128 x 0,6, the temporal resolution of 75 ms and a spatial resolution of 0.33 mm, slice thickness of 0.6 mm, with simultaneous use of two tubes with different voltage (kV 120/100), the current mAs - with programs to reduce radiation exposure Care Dose - is calculated automatically according to the constitution of man.

Post-processing of obtained data was performed on a workstation Syngo Via, in the application of CT-Soronary with automatic longitudinal separation of each coronary artery In view of image quality was analyzed data from end-diastolic phase of the cardiac cycle (80% R-R), or evaluated complex of multiphase images. We analyze the state of the main arteries of the main coronary: left anterior descending artery, the circumflex artery and the right coronary artery (LAD, CA, RCA). We performed estimation of coronary artery stenosis of segments according to the American Heart Association (AHA). Results were displayed in percentage. Obtained data was compared with those obtained using the reference method - X-ray coronary angiography, which was performed according to standard protocol

Results: comparison of results of coronary angiography and MSCT using correlation analysis showed the presence of strong direct significant correlation coefficients in the evaluation of coronary artery disease according to two methods. It was demonstrated a high inter-operator and intraoperator reproducibility of MSCT in the study of vessels conditions. Following characteristics of the method related to the identification of coronary artery stenosis segments: sensitivity - 95.8%, specificity - 92.8%, diagnostic accuracy - 95.1%, positive predictive value - 97.9%, negative predictive value - 86.6 %.

It was concluded that the high importance of the method of MSCT in the diagnosis of cardiovascular diseases and the need for its widespread use in cardiology practice.  

 

References 

1.    Chazov E.I. Perspektivyi kardiologii v svete progressa fundamentalnoy nauki. [Prospects of Cardiology in light of the progress of fundamental science.] Ter. Archive. 2009; 9 : 5-8 [In Russ.]

2.    Данилов Н.М., Матчин Ю.Г. и др. Показания к проведению коронарной артериографии. Consilium Medicum. Болезни сердца и сосудов. 2006; 1(1). Danilov N.M., Matchin Yu.G. et al. Pokazaniya k provedeniyu koronarnoy arteriografii. Consilium Medicum. Bolezni serdtsa i sosudov. [Indications for coronary arteriography. Consilium Medicum heart disease and vascular. ]2006; 1(1) [In Russ.].

3.    Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

4.    Sun Z., Aziz YF., Ng K.H. Coronary CT angiography: how should physicians use it wisely and when do physicians request it appropriately. Eur. J. Radiol. 2012; 81: 684-687.

5.    Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography. Am. Heart J. 2005; 149: 1112-1119.

6.    Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

7.    Achenbach S., Marwan M., Schepis T. et al. High-pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

8.    Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

9.    Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013; 111: 510-515.

10.  De Graaf F.R., Schuijf J.D., Van Velzen J.E. et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur. Heart J. 2010; 31: 1908-1915.

 

Abstract:

Aim: was to show possibilities of magnetic resonance imaging (MRI) in the detection and characterization of neoplasms of the heart.

Materials and methods: we retrospectively studied clinical cases of heart neoplasms, diagnosed and operated in Federal National Center of Cardiovascular Surgery (FNCCS) (Penza) since 2008 tc 2014. All patients on admission underwent echocardiography, after which, in some cases to clarify the topography of neoplasms and features of individual anatomy - MRI was performed. In postoperative follow-up period, control studies were conducted. In all cases, the diagnosis was histologically verified. All operated patients were discharged in satisfactory condition. We made a search and analysis of scientific literature on beam diagnostics of space-occupying lesions of heart.

Results: for the period of 6 years, in FNCCS were examined and surgical treatment of more than 30 thousand patients, of which neoplasms of the heart were detected in 25(0.08%) cases. Cardiac myxoma was diagnosed in 19(76%) patients, of whom in 2(8%) cases, the echocardiographic picture was mixed, that had required magnetic resonance imaging. MRI has also been used in 2(8%) patients with benign and malignant transformation of mesenchyoma, and in few cases (4%) rhabdomyomas, lipomatous hypertrophy, atrial septum, epithelioid leiomyoma of the uterus in the germinating atrium and metastatic melanoma. Also, in some cases, the use of MRI allowed to rule out malignancy and to identify mural thrombus. In 1 case, MRI gave, a detailed study of the morphology and localization of tumors to evaluate its spatial relationship with neighboring structures, study of three-dimensional and functional parameters of the heart. Dynamic mode (Cine-SSFP), planar and volumetric reconstruction (MPR) demonstrated the topography of tumors. That helped a broad understanding of the pre-operative pathology and surgical simplified decision-making. MRI allowed to analyze results of surgical correction and implement dynamic monitoring during the early and late postoperative period.

Conclusions: MRI in the diagnosis of tumors of the heart significantly complements echocardiography, providing a non-invasive multi-modal visualization, necessary for a comprehensive assessment of the topography of lesions, detection of individual anatomical features of intracardiac and extracardiac structures. MRI should be included in the diagnostic algorithm of tumors of the heart, including to assess occured hemodynamic changes.  

 

References 

1.    Centofanti P, Rosa E.Di., Deorsola L. et al. Primary cardiac tumors: carly and late results of surgical treatment in 91 patients. Ann. Thorac. Surg. 1999; 68(4):1236-1241.

2.    Schaff H.V., Mullany C.J. Surgery for cardiac myxomas. Semin Thorac. Cardiovasc. Surg. 2000; 12:77-88.

3.    Moynihan T. J. Is there such a thing as heart cancer? http: www.mayoclinic.org/heart-cancer/expert-answers/ faq-20058130.

4.    Roberts W.C. Neoplasms involving the heart, their simulators, and adverse consequences of their therapy. Bayl Univ. Med. Cent. 2001; 14:358-376.

5.    Sutsch G., Jenni R., L. von Segesser, Schneider J. Heart tumors: incidence, distribution, diagnosis exemplified by 20,305 echocardiographies. Schweiz. Med. Wochenschr. 1991; 121:621-629.

6.    Goswami K.C., Shrivastava S., Bahl V.K., et al. Cardiac myxomas: clinical and echocardiographic profile intern J. Cardiol. 1998; 63 (3):251-259.

7.    Bogaert J., Dymarkowski S., Taylor A.M. Clinical Cardiac MRI. Springer 2005; 549.

8.    Buckley O., Madan R., Kwong R., et al. Cardiac Masses, Part 1: Imaging Strategies and Technical Consideration. AJR. 2011; 197:837-841.

9.    O’Donnell D.H., Abbara S., Chaithiraphan V., et al. Cardiac Tumors: Optimal Cardiac MR Sequences and Spectrum of Imaging Appearances. AJR. 2009; 193: 377387.

10.  Finn J.P, Nael K., Deshpande V., et al. Cardiac MR imaging: state of the technology. Radiology. 2006; 241:338-354.

11.  Fussen S., De Boeck B.W., Zellweger M.J., et al Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. Eur. Heart J. 2011; 32(12):1551-1560.

12.  Belenkov Ju.N., Sinicin V.E., Ternovoj S.K. Magnitno-rezonansnaja tomografija serdca i sosudov[MRI of heart and vessels]. Vidar. 1997; 144 р [In Russ].

13.  Bokerija L.A., Malashenkov A.I., Kavsadze V. Je., Serov R.A. Kardioonkologija [Cardiology]. NCSSH im. A.N. Bakuleva RAMN. 2003; 254 р [In Russ].

14.  Burke A., Virmani R. Atlas of Tumor Pathology. Tumors of the Heart and Great Vessels. Armed Forces Institute of Pathology. 1996.

15.  Butany J., Leong S.W., Carmichael K., Komeda M. A 30-year analysis of cardiac neoplasms at autopsy. Can. J. Cardiol. 2005; 21:675-680.

16.  Telen M., Jerbel R., Krejtner K-F., Barkhauzen J. Luchevye metody diagnostiki boleznej serdca [Beam methods of diagnostics of heart diseases]. MEDpress-inform. 2011; 408 р [in Russ].

17.  Hanson E.C. Cardiac tumors: a current perspective. NY State J. Med. 1992; 92:41-42.

18.  Amano J., Kono T., Wada Y, et al. Cardiac myxoma: its origin and tumor characteristics. Ann. Thorac. Cardiovasc. Surg. 2003; 9:215-21.

19.  Araoz PA., Mulvagh S.L., Tazelaar H.D., et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000; 20:1303-19.

20.  Buckley O., Madan R., Kwong R., et al. Cardiac Masses, Part 2: Key Imaging Features for Diagnosis and Surgical Planning. AJR. 2011; 197:842-851.

 

Abstract:

Palliative surgery plays a major role as a stage of congenitalheart disease treatment.Palliative endovascular interventions are safe n neonates. Such treatment can stabilize patients and adequately prepare them for radical operation and in some cases it is an alternative to classic bypass methodic.

 

References

1.    Бокерия Л.А., Гудкова Р.Г. «Сердечно-сосудистая хирургия-2009». Врожденные пороки системы кровообращения. М.: изд-во НЦССХ им. А.Н. Бакулева РАМН. 2010; 76-115.

2.    Rosano A. et al. Infant mortality and congenital anomalies from 1950 to 1994. An international perspective. J. Epidemiol. Community Health. 2000; 54: 660-666.

3.    Шарыкин А.С. Врожденные пороки сердца. Руководство для педиатров, кардиологов, неонатологов. М.: изд-во «Теремок». 2005; 8-14, 224-234.

4.    Любомудров В.Г., Кунгурцев В.Л., Болсуновский В.А. и др. Коррекция врожденных пороков сердца в периоде новорожденности. Российский вестник перинатологии и педиатрии. 2007; 3: 9-13.

5.    Lacour-Gayet F., Anderson R.H. A uniform surgical technique  for transfer of both simple and complex patterns of the coronary arteries during the arterial switch procedure. Cardiol. in the Young. 2005; 15 (1): 93-101.

6.    Gibbs J.I. Treatment options for coarctation of aorta. Heart. 2000; 84: 11-13.

7.    Zales V.R., Muster A.J. Ballon dilatation angioplasty for the management of aortic coarctation. In C. Mavroudis, C.L. Backer et al. Coarctation and interrupted aortic arch. Cardiac surgery. State of art review. Philadelphia. Huley & Belfus. 1993; 7: 133.

8.    Chen Q., Parry A.J. The current role of hybrid procedures in the stage 1 palliation of patient with hypoplastic left heart syndrome. Eur. J.Cardiolthorac. Surg. 2009; 36: 77-83.

9.    Michel-Behnke I. et al. Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Catheter. Cardiovasc. Interv. 2004; 61  (2): 242-252. 10.  

10.  Bisoi A.K. et al. Primary arterial switch operation in children presenting late with d-transposition of great arteriaes and intact ventricular septum. When is it too late for a primary arterial switch operation? Eur. J. Cardiothorac. Surg. 2010; 38: 707-713.

 

 

 

Abstract:

We have analyzed long-term results of different revascularization strategies in 171 patients with multivessel coronary artery defeat. Duration of follow up observation ranged from 12 to 18 months. Complete revascularization of the myocardium was performed in 63 pts, culprit vessel revascularization - in 86 and incomplete revascularization - in 22 patients. All patients undervwent SYNTAX scoring analysis to find out possible risks of transcutaneus coronary interventions. Survival rate, incidence of myocardial infarction, repeat myocardial revascularization procedures and major adverse cardiac events were comparable among the patients with low and intermediate SYNTAX Score. Among the patients with high SYNTAX Score the incidence of myocardial infarction (8,82%, р = 0,002), repeat PCI procedure (32,35%, р = 0,001) and major adverse cardiac events (32,35%, р = 0,002) was reliably higher compared to patients with low and intermediate SYNTAX Score. The mpact of the SYNTAX Score rate on the long-term results in the different revascularization strategy groups was also analyzed. In the 1st group the incidence of major adverse cardiac events among the patients was comparable. In the 2nd group patients with the high SYNTAX Score rate had reliably higher rate of major adverse cardiac events (43,75%, р = 0,002). The rate of major adverse cardiac events were higher in the 3rd group of patients with the high SYNTAX Score rate compared in patients with low and intermediate SYNTAX Score rate, but this difference didn't reach statistically reliable difference. Use of the strategy of culprit vessel revascularization in the patients with high SYNTAX Score rate, leads to increased rate of major adverse cardiac events and repeat PCI procedures in the long-term follow up period.

 

References 

1.    Silber S. et al. Guidelines for percutaneous        coronary interventions. Eur. Heart. J.2005; 26: 804-847.

2.    Bourassa M.G. et al. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry).

3.    Am. J. Cardiol. 1992; 70: 174. Bourassa M.G. et al. Long-term outcome of 5 patients with incomplete vs complete revascularization after multivessel PTCA (a report from NHLBI PTCA Registry). Eur. Heart. J. 1998; 19: 103-111.

4.    Hannan E.L. et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113; 2406-2412.

5.    Hannan E.L. et al. Incomplete revascularization in the era of drug-eluting stents. Impact on adverse outcomes. J. Am. Coll. Cardiol. Intv. 2009; 2: 17-25.

6.    Ijsselmuiden A.J.J. et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease. A randomized comparison. Am. Heart. J.2004; 148: 467-474.

7.    Martuscelli E. et al. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded. Data from the CABRI trial. Eur. J. of Card.Thorac. Surg. 2008; 33: 4-8.

8.    Van den Brand M.J.B.M. et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial. J. Am. Col. Cardiol. 2002; 39; 559-564.

9.    Беленков Ю.Н., Акчурин Р.С., Савченко А.П. и др. Результаты коронарного стентирования и хирургического лечения у больных ИБС с многососудистым поражением коронарного русла. Кардиология. 2002; 5: 42-45.

10.  Ong A.T.L., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronaryintervention. Circulation. 2006; 114: 249-255.

11.  Patil C.V. et al. Multivessel coronary artery disease. Current revascularization strategies. Eur. Heart. J. 2001; 22: 1183-1197.

12.  Buda A.J. et al. Long-term results following coronary bypass operation. Importance of preoperative factors and complete revascularization. J. Thorac. Cardiovasc. Surg. 1981; 82: 383-290.

13.  Rodriguez A.E. et al. Revascularization strategies of coronary multiple vessel disease in drug eluting stent era. One year follow-up results of ERACI III trial. Eurointervention. 2006; 2: 53-60.

14.  Rodriguez A.E. et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery. 3 years follow-up of the ERACI III registry. Eur. Heart. J. 2007; 28: 2118-2125.

15.  Serruys P.W. et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent. Insights from the Arteкial Revascularization Therapies Study Fart II (ARTS II). Eur. Heart. J. 2007; 28 (4): 433-442.

16.  Serruys P.W. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-972.

17.  Serruys P.W. Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesions. EuroInterv. Arterial, Revascularis. Therap. Study PartII. 2005; 2: 147-156.

18.  Serruys P.W. et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5 (1): 50-56.

 

Abstract:

Purpose. Оf the study was to determine abilities of multislice spiral tomography (MSCT) in detection coronary artery disease (CAD) in patients with atypical angina..

Material and methods. Sixty patients (39 men) with atypical chest pain and suspected ischemic heart disease underwent complex diagnostic strategy. Value of MSCT in detection of significant (more than 50%) coronary artery stenoses was assessed by segmental analysis, vascular bed involvement, and patient analysis.

Results. Significant CAD in 8% of patients with atypical angina was revealed. In 98,7% (58 of 60 cases) MSCT allowed to specify coronary anatomy. In 53 (88,3%) of patients no significant CAD was found, in 5 cases (8,3%) MSCT confirmed significant coronary artery stenoses. Sensitivity, specificity, positive and negative prognostic value of MSCT were correspondingly 100%, 99,3%, 71,4%, 100% in segmental analysis (n = 295). Vascular territory involvement analysis (n = 91) showed 100% sensitivity, 97,7% specificity, positive prognostic value 71,4% and negative prognostic value 100%.

Conclusions. High prognostic value, as well as high sensitivity and specificity of MSCT allow us to include this method into the CAD diagnostic algorithm in patients with atypical chest pain. This method is highly reliable in eliminating of significant CAD and detecting coronary artery stenoses.

 

References 

1.      Синицын В.Е., Устюжанин Д-В. КТ-ангио-графия коронарных артерий. Кардиология. 2006; 1: 20-25.

2.      Терновой  С.К.,  Синицын В.Е.,  Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий.М.: Атмосфера. 2003; 144.

3.      Hoffman M.H. et al. Noninvasive coronary angiography with multislice computed tomography. JAMA. 2005; 293: 2471-2478.

4.      Leber A.W. et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography. A comparative study with quantitative coronary angiography and intravascular ultrasound. J. Am. Coll. Cardiol. 2005; 46: 147-154.

5.      Leschka S. et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur. Heart. J. 2005; 26: 1482-1487.

6.      Mollet N.R. et al. Highresolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005; 112: 2318 -2323.

7.      Raff G.L. et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J. Am. Coll. Cardiol. 2005; 46: 552-557.

8.      Kopp A.F. et al. Coronary arteries: retrospectively ECG-gated multi-detector row CT angiography with selective optimization  of the image reconstruction window. Radiology. 2001; 221:683-688.

9.      Austen W.G. et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad-Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery.   Circulation.   1975;  51:5-40.

10.    Patel M.R. et al. Low diagnostic yield of elective coronary angiography. N. Engl.J. Med. 2010; 362: 886-895.

11.    Leber A.W. et al. Diagnostic accuracy of dual-source multi-slice CT-coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. Eur. Heart. J. 2007; 28: 2354-2360.

12.    Hausleiter J. et al. Non-invasive coronary computed tomographic angiography for patients with suspected coronary artery disease. Тhe Coronary Angiography by Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial. Eur. Heart. J. 2007; 28: 3034-3041.

13.    Goldstein J.A. et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J. Am. Coll. Cardiol. 2007; 49: 863-871.

14.    Hoffmann U. et al. Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease. Patient-versus segment-based analysis. Circulation. 2004; 110: 2638-2643.

 

 

Abstract:

We performed echocardiographic evaluation of 149 women with congenital and acquired heart defects prior to their pregnancy and during the 3d trimester of gestation, as the hemodynamic load reached its peak. It was shown that in patients with surgically corrected cardiac anomalies, echocardiographic findings could stay within physiological limits, otherwise we saw inadequate hemodynamic response and structu-ralchanges.

 

References 

1.            Абрамченко  В.В.  Беременность и  роды высокого риска. М.: «МИА». 2004; 212.

2.            Дидина Н. М., Ефимочкина В.И. Структура заболеваний сердца у беременных в современных условиях. Сб. науч. трудов «Эктрагенитальная патология и беременность».М. 1996; 26-29.     

3.            Егорян Д.С. Оптимизация подходов к ведению беременных, страдающих врожденными пороками сердца. Автореф. дис. канд.мед. наук. Ростов-на-Дону. 2006; 22.

4.            Макацария А.Д., Беленков Ю.Н., Бейлин А.Л. Беременность и врожденные пороки сердца. М.: Руссо. 2001; 305.

5.            Lieber S. et al. Eisenmengers syndrome and pregnancy. Acta Сardiol. 2003; 40: 421-424. 

6.           Затикян Е.П. Оценка нарушений гемодинамики у беременных и родильниц с врожденными пороками сердца. Акуш. и гин. 1998; 4: 64-66.

7.           Алексеева Л. Л. Особенности адаптации кардиореспираторной системы у беременных низкого акушерского риска. Дис. канд. мед. наук. Иркутск. 2004; 190. 

8.            Елисеев О.М. Сердечно-сосудистые заболевания у беременных. М.: Медицина. 1994; 246. 

9.           Жигунова И.А. Оценка неспецифических адаптационных механизмов у женщин в III триместре беременности. Автореф. дис.канд. мед. наук. Рязань. 2002; 15.

10.        Затикян Е.П. Врожденные и приобретенные пороки сердца у беременных. М.: Триада-Х. 2004; 294.

11.        Гриффин Б., Тополь Э. Кардиология. М.:Практика. 2008; 673.

12.        Кулавский В.А., Огий Т.И. Физиология и патология сердца у беременных. Уфа. 2000; 198.

13.        Тетелютина Ф.К. Прогнозирование, доклиническая диагностика и профилактика перинатальной патологии у беременных с пороками сердца. Дис. Д-ра мед. наук (Казанская государственная медицинская академия). 2002; 176.

 

 

Abstract:

A case report of right ventricular outlet (RVO) stenting as palliative treatment of pulmonary artery atresia (PAA) in combination with interventricular septum defect (ISD), in situation when radical surgical intervention has high operative risk due to condition severity and low weight RVO stenting in newborn and children with low weight is made seldom and noted as a case reports. Peculiarity of this case is that intervention was made in patient with extremely low weight and age (age - 6 month, weight - 3 kg) after performed early central aorto-venous bypass and further palliative reconstruction of right ventricular outflow.

 

References

1.     Chang A.C., Hanley F.L., Lock J.E., et. al. Management and outcome of low birth weight neonates with congenital heart disease. J. Pediatr. 1994; 124: 461-6.

2.     Reddy V.M., Elhinney D.B., Sagrado T., et.al. Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. Thorac. Cardiovasc. Surg. 1999; 117: 324-31.

3.     Wernovsky G., RubensteinS.D., Spray T.L. Cardiac surgery in the low-birth weight neonate: new approaches. Clin. Perinatol. 2001; 28:249-4.

4.     Laudito А., Varsha M., Bandisode J., Lucas F. et al. Right Ventricular Outflow Tract Stent as a Bridge to Surgery in a Premature Infant with Tetralogy of Fallot. Ann. Thorac. Surg. 2006; 81:744-746.

5.     Kirklin J. V., Barrat-Boyes. Cardiac surgery J V. New York: Churhill Livingstoun 2003.

6.     Sahu Raj., Syamasundar Rao., Transcatheter Stent Therapy in Children: An Update. Pediat. Therapeut. 2012, S5.

7.     Meadows J., Catheter-Based Interventions for Congenital Heart Disease Meadows Jeff. J. Clin. Exp. Cardiolog. 2012, S: 8.

8.     Gibbs J.L., Uzun O., BlackburnM.E., et. al. Right ventricular outflow stent implantation: an alternative to palliative surgical relief of infundibular pulmonary stenosis. Heart. 1997; 77:176-9.

9.     Sugiyama H., Williams W., Benson L.N. Implantation of endovascular stents for the obstructive right ventricular outflow tract Heart. 2005; 91:10581063.doi:10.1136/ hrt.2004.034819.

10.   Alwi M., Alwi M., Choo K.K., Latiff H.A., et. al. Initial results and medium-term follow-up of stent implantation in patent ductus arteriosus in ductdependent pulmonary circulation. J. Am. Coll. Cardiology 2004; 44(2):438-45. 

11.   Gladman G., Mc Crindle B.W., Williams W.G., et. al. The modified blalock-taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the currentera. J. Thorac. Cardiovasc. Surg. 1997; 114:25-30.

 

Abstract:

Diseases of the circulatory system in a few decades are one of the major causes of death and disability in the population in many countries around the world. In Russian Federation, a number of newly diagnosed cases of coronary heart disease and mortality of the working population of this pathology is growing. In clinical practice at the present time, various radiological techniques assess the condition of the heart and coronary vessels, determine the location and volume of lesions. In the available literature, however, we found no data on methods of research that would reveal the correlation between the X-ray anatomy of coronary vessels and structural and functional state of the heart muscle. Thus, the need for comprehensive scientific research is obvious. Results of this study will, on the basis of survey data, using the methods of radiation diagnosis, objectively assess the level of metabolic and structural and functional state of the cardiomyocytes in cardiac patients. This will improve the accuracy and informativeness of diagnosis, as well as the increase of the control of effectiveness of therapy and quality of patients' life with cardiac diseases. 

 

References

1.     Pakkal M., Raj V., McCann G.P Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischemia and viability assessment. The British Journal of Radiology. 2011; 84: S280-S295.

2.     Boqueria L.A., Gudkova R.G. Cardiac Surgery - 2010. Diseases and congenital malformations of the circulatory system. Moscow: Publishing Bakoulev center for cardiovascular surgery of RussianAcademy of Medical Sciences. 2011. 192 p [In Russ].

3.     Lindenbraten L.D. Beam diagnostics: achievements and challenges of modern times. Radiology - practice. 2007, 3: 4-15[In Russ].

4.     Sharafeev A.Z. Diagnosis of associated atherosclerotic lesions of different pools in CHD patients. Kazan Medical Journal. 2009; XC (2), 145-148[In Russ].

5.     Shahov B.E., Krinina I.V., Matusowa E.I., Vostriakova L.V. Classic radiologic differential diagnosis of angina syndrome. Medical almanac. 2007, 1: 58-61[In Russ].

6.     Ternovoy S.K., Akchurin R.S., Fedotenkov I.S. et all. Multislice computed tomography in the diagnosis of non-invasive cross-mammaro and aortocoronary bypass grafts. Kuban Research Medical Bulletin. 2010, 6: 147-153 [In Russ].

7.     Nudnov I.N., Bolotov P.A., Rudenko B.A. Comparative analysis of the morphology after implantation of coronary atherosclerosis and uncovered stents drug according to coronary angiography and intravascular ultrasound. Medical imaging. 2011, 5: 104-113 [In Russ].

8.     Lishmanov J.B., Markov V.A., Krivonogov N.G. Possibilities of radionuclide methods in forecasting the results of coronary artery bypass grafting in patients after myocardial infarction. Diagnostic and Interventional Radiology. 2008, 2 (4): 17-25 [In Russ].

9.     The methods of radiologic diagnosis: a manual. S.K. Ternovoy and others (Ed. Ed. Sapozhkova L.P.). Rostov n / D: Phoenix. 2007, 137 p. [In Russ].

10.   Sinicyn V.E., Fomina I.G., Pisarev M.V., Gagarina N.V. Diagnostic and prognostic significance of detection of coronary calcification in the preclinical stage of ischemic heart disease. Cardiovascular therapy and prevention. 2004, 3 (5): 118-125 [In Russ].

11.   Kothawade K., Noel Bairey Merz C. Microvascular coronary dysfunction in women - pathophysiology, diagnosis and management. Curr. Probl. Cardiol. 2011; 36 (8): 291-318.

12.   Gorge G., Ge J., von Birgelen C., Erbel R. Intracoronary ultrasound - the new gold-standart? Zeitschrift fur Kardiologie. 1998; 87 (8): 575-585.

13.   Movsesyants M.Y, Ivanov V.A., Trunin I.V. Intravascular ultrasound with Virtual Histology in lesions of the coronary arteries. Cardiology. 2009, 12: 58- 61 [In Russ].

14.   Veselova T.N., Merkulova I.N., Yarovaya E.B., Ruda M. J. Evaluation of myocardial viability Metolit MSCT for the prediction of postinfarction left ventricular remodeling. Regional circulation and microcirculation. 2013, 1 (45): 17-24 [In Russ].

15.   Stukalova O.V., Vlasova, E.E., Tarasov L.V., Ternovoy S.K. Magnetic resonance imaging of the heart in patients with postinfarction cardiosclerosis preoperative surgical myocardial revascularization. Regional circulation and microcirculation. 2013, 1 (45): 36-41[ In Russ].

16.   Hofer M. Computed tomography. A basic guide. Moscow: Medlit. 2006, 208 p [In Russ].

17.   Galanski M., Prokop M. Spiral and multislice CT of the body. New York, Thieme. 2003.

18.   Ropers D., BaumU., Karsten P. et al. Detection of coronary artery stenoses with thin slice multi detector row spiral computed tomography and multiplanar reconstruction. Circulation. 2003; 107: 664-666.

19.   Morozov S.P., Nasnikova I.Y, Sinicyn V.E., Ternovoy S.K. Multidetector computed tomography. (Eds. Thorn SK). M: GEOTAR Media. 2009; 112 p [In Russ].

20.   Boev S.S., Dotsenko N.Y, Gerasimenko L.V., Shekhunova I.A. Coronary artery calcification as a marker of the risk of coronary artery disease and a predictor of cardiovascular events. Health Care in Chuvashia. 2012, 1: 74-79 [In Russ].

21.   Agatston A.S., Janowitz W.R., Hildner F.J. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990; 15: 827-832.

22.   Lau G.T., Ridley L.J., Schieb M.C. et al. Coronary artery stenoses: detection with calcium scoring, CT angiography and both methods combined. Radiology. 2005; 235: 415-422.

23.   General and military radiology: a textbook. (Eds. Trufanova GE). St. Petersburg.: MMA, Medkniga ELBI SPB. 2008, 480 p [In Russ].

24.   Perioperative rehabilitation of patients with complicated forms of ischemic heart disease. (By red.prof. V. Burly.) - Ufa. 2012, 336 p [In Russ].

25.   Sicari R., Nihoyannopoulos P., Evangelista A. et al. Stress Echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur. J. Echocardiogr. 2008; 9: 415-37.

26.   Klein C., Nekolla S.G., Bengel F.M. et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002; 105: 162-167.

27.   Wagner A., Mahrholdt H., Holly T.A., Elliott M.D. et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003; 361: 374-379.

28.   Lishmanov J.B., Efimova I.J., Chernov V.I. et al. Scintigraphy as a tool for diagnosis, prognosis and monitoring of the treatment of heart disease. Siberian Journal of Medicine (Tomsk). 2007, 22 (3): 74-77 [In Russ].

29.   Ryzhkova D.V., Kolesnychenko M.G., Boldueva S.A., Kostin J.S. The study of coronary hemodynamics methods of positron emission tomography in patients with cardiac syndrome X. Siberian Medical Journal (Tomsk). 2012, 27 (2): 50-56 [In Russ].

30.   Nekolla S., Reder S., Saraste A. et al. Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model. Circulation. 2009; 119(17): 2333-2342. 

31.   Gerber B.L., Ordoubadi F.F., Wijns W. et al. Positron emission tomography using 18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of 18F- fluorodeoxyglucose positron emission tomography for the detection of myocardial viability. Eur. Heart. J . 2001: 22: 1691-701.

 

Abstract:

Surgical treatment of aortic valve pathology is an actual problem of modern medicine. Aortic valve pathology is widely spread in population on a stable high level. Due to a large amount of patients with no possibility of open surgical treatment of aortic valve pathology modern hybrid methods of treatment, such as transcatheter aortic valve implantation are being actively proposed and modified.

MSCT angiography before transcatheter aortic valve implantation is obligatory procedure. Data obtained by MSCT is extremely necessary to define the possibility and the access path of transcatheter aortic valve implantation. MSCT allows to select the size and type of aortic valve prosthesis.

Appearance of modern MSCT scanners with 320-640 row of detectors will increase the leading role of MSCT in preoperative inquiry of patients with planned transcatheter aortic valve implantation.

 

References

1.     Nkomo V.T., Gardin J.M., Skelton T.N. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011.

2.     Charlson E., Legedza A.T.R., Hamel M.B. Decisionmaking and outcomes in severesymptomatic aortic stenosis. J. Heart Valve Dis. 2006; 15: 312-321.

3.     Iung B., Baron G., Butchart E.G., Delahaye F.. Gohlke-Barwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 2003; 24: 1231-1243. 

4.     Varadarajan P., Kapoor N., Bansal R.C., Pai R.G. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann. Thorac. Surg. 2006; 82: 2111-2115.

5.     Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J. 1992; 13:704-708.

6.     Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106: 3006-3008.

7.     Webb J.G., Pasupati S., Humphries K., Thompson C., Altwegg L., Moss R., Sinhal A., Carere R.G., Munt B., Ricci D., Ye J., Cheung A., Lichtenstein S.V. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007; 116: 755-763.

8.     Callander V. Computed tomography. M. Technosphere, 2006. C-17-23 [In Russ.]

9.     Ternovoy S.K., Sinitsyn V.E. Spiral CT and cathode ray angiography. M. Vidar, 1998. C-23-47 [In Russ.]

10.   Sinitsyn V.E., Achenbach S. Electron Beam Computed Tomography. In: M.Oudkerk (ed). Coronary Radiology. Berlin: Springer, 2004.

11.   Bridgewater B., Keogh B., Kinsman R., Walton P Sixth national adult cardiac surgical database report. 2008 [cited 2011 Feb 9].

12.   Ludman PF. British Cardiovascular Intervention Society audit returns: adult interventional procedures Jan 2009 to Dec 2009. BCIS Meeting; 2010 Oct: Cardiff, Wales. Рр17-34.

 

Abstract:

Aim: was to study properties of nanostructured carbon coating stents in coronary arteries with the help of intravascular ultrasonic visualization.

Materials and Methods: experimental implantation of stents in coronary artery was performed on 8 yearling sheep. Estimation of bioinertness properties of stents was made by intravascular ultrasonic method on the 14, 28, 180 day. Bioinertness properties were estimated in comparison with analogical bare-metal stents.

Results: The analysis of results showed that in early stages (up to 28 days) experimental samples of stents cause less formation of trombus than simple balloon-extendable stents. In the period of late outcomes, coronary nanostructured carbon coating stents have lower level of «in-stent stenosis».

Conclusion: stent implantation with nanostructured carbon coating does not prevent the natural reparative processes taking place in the artery wall, does not cause the formation of thrombotic masses under standard doses of antiaggregants. Experimental stents significantly less affected in-stent stenosis, than stents without surface modification, indicating their higher bioinertness. 

 

References

1.     Libby P., Ganz P. Restenosis revisited.- new tsrgets, new therapies. - N. Egl.S.Med. 1997; 37: 418-419.

2.     Aref'eva T.I. et. al. Uvelichenie jekspressii monocitarnyh molekul adgezii i obrazovanija monocitotrombocitarnyh agregatov v krovi pri koronarnom restenoze [Increased expression of monocyte adhesion molecules and the formation of aggregates monotsitotrombotsitarnyh blood in coronary restenosis]. Terapevticheskijarhiv. 2002; 4:46-49 [In Russ].

3.     Morice M.C. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revesculazation. N. Engl. J. Med. 2002; 346:1773-1780.

4.     Topol E.J. Artery size, neointima and remodeling time for some standards. J. Am. Coll Cardiol. 1998; 32:2087-2094.

5.     Kremneva L.V. Vospalenie kak faktor riska restenoza i serdechno-sosudistyh oslozhnenij posle chreskozhnyh intrakoronarnyh vmeshatel'stv [Inflammation as a risk factor for restenosis and cardiovascular events after percutaneous intracoronary intervention]. Terapevticheskij arhiv. 2006; 3: 89-95 [In Russ].

6.     Lazarenko O.N. Vlijanie pokrytij stentov na tromboobrazovanie i razvitie restenozov [Tekst] [Influence of coatings on the stent thrombosis and restenosis. [Text]. Prakticheskaja angiologija. 2007; 2 (7): 10-13 [In Russ].

7.     Demin V.V. Klinicheskoe rukovodstvo po vnutrisosudistomu ul'trazvukovomu issledovaniju [Clinical guidelines for intravascular ultrasound]. O. IPK JuzhnyjUral. 2005; 400 s. [In Russ].

8.     Fedorchenko AN., Osiev A.G., Kochkina T.A., Protopopov A.V. Prognozirovanie klinicheskih rezul'tatov jendovaskuljarnogo vosstanovlenija prosveta stentirovannyh koronarnyh arterij. Diagnosticheskaja i intervencionnaja radiologija [Prediction of clinical results of endovascular stented recovery lumen of the coronary arteries. Diagnostic and intewentional Radiology. 2007; 3(1): 54-65 [In Russ].

9.     Vlodaver Z., French R., Van tassel R.A. et. al. Corellation of the atamortem coronary arteriogram and the postmortem specimen. Circulation. 1973; 47:162-9.

10.   Grondin C.M., dyrda I., Pasternac A. et al. Discrepancies between cineangiographic and postmortem findings in partients with coronary artery disease and recent myocardial revascularheart diseases: comparison of ciuneangiographic and necropsy findings. Ann. Intern. Med. 1979; 91:350-6.

12.   Isner J.M., Kishel J., Kent K.M. et. al. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic - histologic correlative analisys in 28 patients. Circulation. 1981; 63: 1056-64.

13.   Ivanov V.A., Movsesjanc M.Ju., Trunin I.V. Vnutrisosudistye metody issledovanija v intervencionnoj kardiologii [Intravascular methods of research in interventional cardiology]. Medpraktika. M. 2008; 112S. [In Russ].

14.   Nakamura S., Colombo A., Gaglione A. et al. Intracoronary ultrasound observations during stent implantations. Circulation. 1994; 89; 2026-34.

15.   Colombo A., Hall P., Nakamura S. et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 91: 1676-88.

16.   Goldberg S.L., Colombo A., Nakamura S. et al. Benefit of intracoronary ultrasound in the deployment of Palmaz - Schatz stents. J. Am. Coll. Cardiol. 1994; 24:996-1003. 

 

 

Abstract:

This case report is about endovascular treatment of pulmonary arteriovenous malformations accompanied by severe arterial hypoxemia in the newborn. The peculiarity of this case is the extreme rarity of manifestation and successful treatment of the pathology in infancy The second feature was the use of vascular occlude devices. Currently due to the sporadic clinical observations in newborn, we consider to appropriate description of this case, focusing on the technical aspects of the intervention. 

 

References

1.     Khurshid I., Downie G. Pulmonary arteriovenous malformation. Postgrad Med J 2002; 78:191-7.

2.     Andrade C., Ferreira H., Fischer G. Congenital lung malformations. Bras. Pneumol. 2011; 37: 259-271.

3.     Churton T., Multiple aneurysms of pulmonary artery. BMJ. 1897; 1: 1223.

4.     Mitchell R., Austin E. Pulmonary arteriovenous malformation in the neonate. J. Pediatr. Surg. 1993; 28: 1536-1538.

5.     Porstmann W. Therapeutic embolization of arteriovenous pulmonary fistula by catheter technique. Current concepts in pediatric radiology. Springer. 1977; 23-31.

6.     Pollak J.S., Saluja S., Thabet A. et al. Clinical and Anatomic Outcomes after Embolotherapy of Pulmonary Arteriovenous Malformations. J. Vasc. Interv. Radiol. 2006; 17: 35-45.

7.     Cirstoveanu C., Balomir A., Bizubac M., Costinean S. Pulmonary arteriovenous malformation - a rare cause of hypoxemia. Practic. Med. 2012; 7: 28.

8.     Koppen S., Korver C., Dalinghaus M., Westermann C. Neonatal pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasia. Arch. Dis. Child. Fetal Neonatal Ed. 2002; 87: 226-227.

9.     Guidone P., Burrows P., Blickman J. Pediatric case of the day. Congenital pulmonary arteriovenous malformation. Am. J. Roentgenol. 1999; 173: 818-819.

10.   Trivedi K., Sreeram N. Neonatal pulmonary arteriovenous malformation. Arch. Dis. Child. 1996; 74: 80.

11.   Ravasse P., Maragnes P., Petit T., et al. Total pneumonectomy as a salvage procedure for pulmonary arteriovenous malformation in a newborn: report of one case. J. Pediatr. Surg. 2003; 38: 254-255.

12.   Trerotola S., Pyyeritz R . PAVM Embolization: An Update. AJR. 2010; 195: 837-845

13.   Swanson K., Prakash U., Stanson A. Pulmonary arteriovenous fistulas: Mayo Clinic experience. Mayo Clinic Proc. 1999; 74: 671-680.

14.   Shapiro J., Paul C. Stillwell - Diffused Pulmonary arteriovenous malformation (Angiodysplasia) with unusual histologic features: Case report and review of the literature. Pediatric Pulmonology 1995; 21: 255-261.

15.   Белозеров Ю.М., Детская кардиология. М.: Медпрессинформ. 2004;167-180. Belozerov Ju. M., Detskaja kardiologija [Pediatrics cardiology]. M.: Med-pressinform. 2004;167-180 [In Russ]. 

 

Abstract:

Aim: was to analyse possibilities of multislice computed tomography in patients with coronary vessels' pathology

Results: we performed the analysis of published data on the use of multislice computed tomography in the coronary heart disease diagnostics. Data on the development of the method are presented: it is indicated that its diagnostic efficiency is related to technological improvements, accompanied by the appearance of each successive generation of multislice computed tomography The possibilities of using scanners from 16- to 230-slice scanners with two sources of energy, advantages of «dual energy» regime of application (dual-energy CT) in the coronary disease diagnostic are considered. Given constraints of the method diagnostic efficacy - artifacts associated with movements and severe calcification.

Conclusions: implementation of the method in cardiology practice can promote its consideration as a promising alternative to invasive diagnostic coronary angiography Further development of the technology can allow multislice computed tomography to become the main method of diagnosis of coronary heart disease and other cardiovascular diseases. 

 

References

1.     Paul J.F., Dambrin G., Caussin C. et al. Sixteen-slice computed tomography after acute myocardial infarction: from perfusion defect to the culprit lesion. Circulation. 2003; 108: 373-374.

2.     Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

3.     Costello P., Lobree S. Subsecond scanning makes CT even faster. Diag. Imaging. 1996; 18: 76-79.

4.     Taguchi K., Aradate H. Algorithm for image reconstruction in multi-slice helical CT. Med. Phys. 1998; 25: 550-561.

5.     Flohr T.G., Schaller S., Stierstorfer K. et al. Multidetector row CT systems and image-reconstruction techniques. Radiology. 2005; 235: 756-773.

6.     Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography Am. Heart J. 2005; 149: 1112-1119.

7.     Goldman L.W. Principles of CT: multislice CT. J. Nucl. Med. Technol. 2008; 36: 57-68.

8.     Lewis M., Keat N., Edyvean S. 16 Slice CT scanner comparison report version 14, 2006. Available from: URL: http://www.impactscan.org/reports/Report06012.htm

9.     Achenbach S., Ropers D., Pohle F.K. et al. Detection of coronary artery stenoses using multi-detector CT with 16 x 0.75 collimation and 375 ms rotation. Eur. Heart J. 2005; 26: 1978-1986.

10.   Kuettner A., Beck T., Drosch T. et al. Image quality and diagnostic accuracy of non-invasive coronary imaging with 16 detector slice spiral computed tomography with 188 ms temporal resolution. Heart. 2005; 91: 938-941.

11.   Garcia M.J., Lessick J., Hoffmann M.H. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006; 296: 403-411.

12.   Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

13.   Flohr T.G., McCollough C.H., Bruder H. et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 2006; 16: 256-268.

14.   Achenbach S., Marwan M., Schepis T. et al. High- pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

15.   Ruzsics B., Lee H., Zwerner P. et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur. J. Radiol. 2008; 18: 2414-2424.

16.   Jiang H.C., Vartuli J., Vess C. Gemstone - the ultimatum scintillator for computed tomography. Gemstone detector white paper.London: GE Healthcare, 2008: 1-8

17.   Mori       S., Endo M., Obata T. et al. Clinical potentials of the prototype 256-detector row CT-scanner. Acad. Radiol. 2005; 12: 148-154.

18.   Hoe J., Toh K.H. First experience with 320-row multidetector CT coronary angiography scanning with prospective electrocardiogram gating to reduce radiation dose. J. Cardiovasc. Comput. Tomogr. 2009; 3: 257-261.

19.   De Graaf F.R., Schuijf J.D., Van Velzen J.E. et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur. Heart J. 2010; 31: 1908-1915.

20.   Sun Z., Jiang W. Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur. J. Radiol. 2006; 60: 279-286.

21.   Pontone G., Andreini D., Bartorelli A. et al. Diagnostic accuracy of coronary computed tomography angiography: a comparison between prospective and retrospective electrocardiogram triggering. J. Am. Coll. Cardiol. 2009; 54: 346-355.

22.   Sun Z., Ng K.H. Diagnostic value of coronary CT angiography with prospective ECG-gating in the diagnosis of coronary artery disease: a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging. 2012; 28: 2109-2119.

23.   Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

24.   Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl. J. Med. 2008; 359: 2324-2336.

25.   Alkadhi H., Stolzmann P., Desbiolles L. et al. Low-dose, 128-slice, dual-source CT coronary angiography: accuracy and radiation dose of the high-pitch and the step-and-shoot mode. Heart. 2010; 96: 933-938.

26.   Hou Y, Yue Y, Guo W. et al. Prospectively versus retrospectively ECG-gated 256-slice coronary CT angiography: image quality and radiation dose over expanded heart rates. Int. J. Cardiovasc. Imaging. 2012; 28: 153-162.

27.   Hou Y, Ma Y, Fan W. et al. Diagnostic accuracy of low-dose 256-slice multidetector coronary CT angiography using iterative reconstruction in patients with suspected coronary artery disease. Eur. Radiol. 2014; 24: 3-11.

28.   Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013; 111: 510-515.

29.   Van Velzen J.E., De Graaf F.R., Kroft L.J. et al. Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry. Int. J. Cardiovasc. Imaging. 2012; 28: 865-876.

30.   Pelliccia F., Pasceri V., Evangelista A. et al. Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected, consecutive patients with suspected coronary artery disease. Int. J. Cardiovasc. Imaging. 2013; 29: 443-452.

31.   Gaudio C., Pelliccia F., Evangelista A. et al. 320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and metaanalysis. Int. J. Cardiol. 2013; 168: 1562-1564.

32.   Li S., Ni Q., Wu H. et al. Diagnostic accuracy of 320-slice computed tomography angiography for detection of coronary artery stenosis: meta-analysis. Int. J. Cardiol. 2013;168: 2699-2705.

33.   Barrett J.F., Keat N. Artifacts in CT: recognition and avoidance. Radiographics. 2004; 24: 1679-1691.

34.   Earls J.P. How to use a prospective gated technique for cardiac CT. J. Cardiovasc. Comput. Tomogr. 2009; 3: 45-51.

35.   Leschka S., Stolzmann P., Schmid F.T. et al. Low kilovoltage cardiac dual-source CT: attenuation, noise, and radiation dose. Eur. Radiol. 2008; 18: 1809-1817.

36.   Ketelsen D., Thomas C., Werner M. et al. Dualsource computed tomography: estimation of radiation exposure of ECG-gated and ECG-triggered coronary angiography. Eur. J. Radiol. 2010; 73: 274-279.

37.   Dikkers R., Greuter M.J., Kristanto W. et al. Assessment of image quality of 64-row Dual Source versus Single Source CT coronary angiography on heart rate: a phantom study. Eur. J. Radiol. 2009; 70: 61-68.

38.   Hoffmann U., Moselewski F., Nieman K. et al. Non-invasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J. Am. Coll. Cardiol. 2006; 47: 1655-1662.

39.   Sun Z. Cardiac CT imaging in coronary artery disease: Current status and future directions. Quant Imaging Med. Surg. 2012; 2: 98-105.

40.   Halpern E.J., Savage M.P., Fischman D.L., Levin D.C. Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results. AJR Am. J. Roentgenol. 2010; 194: 1257-1262.

41.   Sun Z., Aziz YF., Ng K.H. Coronary CT angiography: how should physicians use it wisely and when do physicians request it appropriately Eur. J. Radiol. 2012; 81: 684-687. 

 

 

Abstract:

Aim: was to analyze long-term results of coronary artery stenting with drug-eluting stents «Zotarolimus» and bare metal stents in patients with a concomitant diabetes mellitus type II.

Materials and methods: 37 patients with ischemic heart disease and concomitant diabetes mellitus type II were selected for analysis; they underwent implantation of stents without drug coverage («Intergrity» «Medtronic») or stents with drug-eluting «Zotarolimus» («Resolute Integrity» «Medtronic»). All patients were divided into 2 groups: first group consisted of 11 patients, who underwent implantation of bare metal stents, second group - 26 patients who underwent implantation of drug-eluting stents, «Zotarolimus». Follow-up period was 26±4 months. Criteria of stenting efficiency were: angiographic assessment of coronary arteries anatomy in control angiography after stent implantation, reccurence of angina or functional class increase, the survival rate in the nearest postoperative period, before discharge, but not more than 30 days, and in the early post-operative period up to 6 months. In the medium-distant post-operative period - 12 months, and in the late postoperative period - 24 months.

Results: all patients underwent successfully performed endovascular revascularization. The optimal angiographic result was achieved in all patients. Regression of ischemic changes on ECG data and increase myocardial contractility by echocardiography data also were marked in all patients. In long-term follow-up period, in 5 (45%) patients with bare metal stents we noted the appearence of hemodynamically significant restenosis, that needed performance of secondary angioplasty with stenting.

Conclusion: the use of antiproliferative drug-eluting stents «Zotarolimus» is possible in treatment of patients with coronary artery disease and comorbid diagnosis of diabetes mellitus type II. Bare metal stents in coronary stenting in patients with concomitant diagnosis of diabetes mellitus type II is impractical due to developing in-stent restenosis (45% of patients). 

 

References

1.     Kereiakes D.J., Cutlip D.E., Applegate R.J., Wang J., Yaqub M., Sood P., Su X., Su G., Farhat N., Rizvi A., Simonton C.A., Sudhir K., Stone G.W. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Limus Eluting Coronary Stent System). J. Am. Coll. Cardiol. 2010 Dec 14; 56(25):2084-2089.

2.     Petrova K.N., Kozlov S.G., Ljakishev A.A., Savchenko A.P. Vlijanie saharnogo diabeta 2 tipa na rezul'taty jendovaskuljarnogo lechenija IBS s pomoshhju stentov s lekarstvennym pokrytiem (dannye godichnogo nabljudenija) [Influence of diabetes mellitus type 2 on results of endovascular treatment of IHD with help of drug-eluting stents (data monitoring for one year)]. Kardiohgija. 2006; 12: 22-6 [In Russ].

3.     Abizaid A., Costa M.A., Blanchard D. et al. Sirolimus-Eluting Stents Inhibit Neointimal Hyperplasia in Diabetic Patients. Insights from the RAVEL Trial. Eur. Heart J. 2004; 25: 107-12.

4.     Moussa I., Leon M.B., Baim D.S. et al. Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients. Circulation .2004; 109: 2273-8.

5.     Hermiller J.B., Raizner A., Cannon L. et al. TAXUS-IV Investigators. Outcomes With the Polymer-Based Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus: the TAXUS-IV trial. JACC. 2005; 45: 1172-9.

6.     Sabate M., Jim Onez-Quevedo P., Angiolillo D.J. et al. Randomized Comparison of Limus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients. Circulation. 2005; 112: 2175-83.

7.     Jensen J., Lagerqvist B., Aasa M., Sarev T., Nilsson T., Tornvall P. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise? J. Intern. Med. 2006 Aug; 260(2):118-24.

8.     Jain A.K., Lotan C., Meredith I.T., Feres F., Zambahari R., Sinha N., Rothman M.T. E-Five Registry Investigators. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry. Heart. 2010 Jun; 96(11):848-53. doi: 10.1136/hrt.2009.184150.

9.     Stettler C., Allemann S., Egger M. et al. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart. 2006; 92: 650-7.

10.   Scheen A.J., Warzee F. Diabetes Is Still a Risk Factor for Restenosis After Drug-Eluting Stent in Coronary Arteries. Diabetes Care. 2004; 27: 1840-1.

11.   Park K.W., Lee J.M., Kang S.H., Ahn H.S., Kang H.J., Koo B.K., Rhew J.Y, Hwang S.H., Lee S.Y, Kang T.S., Kwak C.H., Hong B.K., Yu C.W., Seong I.W., Ahn T., Lee H.C., Lim S.W., Kim H.S. Everolimus-eluting xience v/promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. JACC. Cardiovasc. Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201. 

 

Abstract:

Aim: was to perform indirect estimation of pumping function of left ventricle (LV) in patients with ischemic heart disease (IHD), before and after mini-invasive intracoronary procedures or elimination of cardiac arrhythmias, basing on condition of pulmonary circulation.

Material and methods: research includes data of 44 patients with IHD (aged 43-89), who were admitted to the hospital with acute coronary syndrome (ACS) or cardiac arrhythmia. Estimation of pulmonary flow condition in IHD patients was made basing on data of chest multislice computec tomography (MSCT), changes of density of lung parenchyma in selected volume of lung before and after coronary stenting/placement of pacemaker, disruption of ectopic lesions and conduction pathway

Results: sighs of reliable changes in pulmonary circulation as local lung pneumatization changes with increased densitometric value within 10 hounsfield units (HU) after mini-invasive surgical treatment were found in 19 patients.

Conclusions: the study has showed high sensitivity of lung MSCT in diagnostics of left ventricular disfunction within coronary blood flow changes and normalization of cardiac rhythm. 

 

References

1.     Информационный бюллетень ВОЗ N 317 Март 2013г. http://www.who.int/mediacentre/factsheets/ fs317/ru/. Informacionnyj bjulleten' VOZ N 317 Mart 2013g [WHO Information bulletin # 317, march 2013]. http://www.who.int/mediacentre/factsheets/fs317/ru/ [In Russ]

2.    Demograficheskij ezhegodnik Rossii, 2012 [Demographic yearbook of Russian Federation, 2012]. Stat sb. Rosstat. M: 2012; 535 [In Russ].

3.     Oganov R.G., Maslennikova G.Ja. Demograficheskie tendencii v Rossijskoj Federacii: vklad boleznej sistemy krovoobrashhenija [Demographic trends in Russian Federation: the role of diseases of blood circulation]. Kardiovask. ter. i prof 2012; 1:5-10 [In Russ].

4.     Koncevaja A.V, Kalinina A.M., Koltunov I.E., Oganov R.G. Social'no-jekonomicheskij ushherb ot ostrogo koronarnogo sindroma v Rossijskoj Federacii.GNIC profilakticheskoj mediciny [Social-economic lesion of acute coronary syndrome in Russian Federation]. Racionarnaja farmakoterapija v kardiologii. 2011 7(2): 158-166 [In Russ].

5.     Salvador M.J., Sebaoun, F. Sonntag, P. et. al. European Study of Ambulatory Management of Heart Failure . Rev. Esp. Cardiol. 2004;57(12):1170-8.

6.     Obrezan A.G., Vologdina I.V. Hronicheskaja serdechnaja nedostatochnost [Chronic heart insufficiency]'. «Vita Nova». 2002; 320 s [In Russ].

7.     Belenkov Ju.N., Mareev VJu., Principy racional'nogo lechenija serdechnoj nedostatochnosti [Principles of heart insufficiency treatment]. M. 2000; 173s [In Russ].

8.     Rezcalla S.H., Kloner R.A. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc. Interv. 2008; 72: 950-957.

9.     Tihonov K.B. Funkcional'naja rentgenoanatomija serdca [Functional endovascular anatomy]. Izd. Medicina. M. 1990; 272 s [In Russ].

10.   Sebastian C.A., Bekkers M., Waltenberger J. Microvascular Obstruction: underlying pathophisiology and clinical diagnosis. J. Am. Coll. Car. 2010; 55:16491660.

11.   Abbate A., Kontos M.C. No-Reflow: the next challenge in treatment of ST-elevation acute myocardial infarction. Eur. Heart J. 2008; 29: 1795-1797.

12.   Beljalov F.I Aritmii serdca [Cardiac arrythmias]. RIO IMAPO. 2011; 333s [In Russ].

13.   Trufanov G.E., Zheleznjak I.S., Rud' S.D., Men'kov I.A. MRT v diagnostike ishemicheskoj bolezni serdca [MRI in diagnostics of ischemic heart diseases]. Jelbi-SPb. 2012; 64 s [In Russ].

14.   Гранов А.М., Тютин Л.А. Позитронно-эмиссионная томография. Издательстово Фолиант. 2008;368 c. Granov A.M., Tjutin L.A. Pozitronno-jemissionnaja tomografija [Positron Emission Tomography]. Izdatel'stovo Foliant. 2008;368 s [In Russ].

15.   Turner F., Lau F., Jacobson G. A method for estimation of pulmonary venosus and arterial pressures from the routine chest roentgenogram. Amer. J. Roentgenol. 1972; 116: 97-106.

16.   Petrenko I.E. Rentgenologicheskie projavlenija levozheludochkovoj nedostatochnosti serdca i rentgenodiagnostika nekotoryh oslozhnenij pri ostrom infarkte miokarda [Radiographic manifestations of left ventricle insufficiency and radiographic diagnostics of complications of acute coronary syndrome]. Avtoreferat. dis. uchen. ctep. kand. med. nauk L. 1982 [In Russ].

17.   Storto M.L., Kee S.T., Golden, J.A. Webb W.R. Hydrostatic pulmonary edema: high-resolution CT findings. AJR:165, October 1995: 817-820.

18.   Kato S., Nakamoto T., Iizuka M. Early diagnosis and estimation of pulmonary congestion and edema in patients with left-sided heart disease from histogram. Pulmonary CT Number. ST 1996; 109:1439-45.

19.   Pelosi P, Gama de Abreu M. Lung CT scan. The Open Nuclear Medicine Journal. 2010; 2: 86-98.

20.   Hanneman K., Nguyen E.T., Crean A.M. Hypertrophic cardiomyopathy complicated by pulmonary edema in the postpartum period. Hinduri рublishing corporation сase reports in radiology. V. 2013; Article ID 802352, 3 pages http://dx.doi.org/10.1155/2013/80235.

21.   Claudia M., Cunha R., Edson M., Rodrigeus R., Hydrostatic pulmonary edema: high-resolution computed tomography aspects. J. Bras. Pneumol. 2006; 32 (6): 515-22.

22.   Gonzales J., Verin A. Non-Cardiogenic Pulmonary Edema, Lung Diseases - Selected State of the Art Reviews, Ed. Dr. Elvisegran M. I. 2012, ISBN: 978-953-51-0180-2, InTech, Available from:http://www.intechopen.com/ books/lung-diseases-selected-state-of-the-art- reviews/non-cardiogenic-pulmonary-edema.

23.   Min'ko B.A., Vologdina I.V., Borodich P.L. Rol' kompjuternoj tomografii legkih u bol'nyh ishemicheskoj boleznju serdca v ocenke funkcii levogo zheludochka pri maloinvazivnyh hirurgicheskih vmeshatel'stvah [The role of computed tomography of lungs in estimation of left ventricle function during mini-invasive interventions in patients with ischemic heart disease]. REJR. 2015; 5(1): 64-67 [In Russ]. 

 

 

 

Abstract:

Background: case report of a rare congenital anomaly - the diverticulum of the right ventricle of the heart, revealed by echocardiography and magnetic resonance imaging (MRI) of the heart.

Aim: was to show possibilities in detection and differential diagnosis of diverticulum of the right ventricle.

Materials and methods: patient, 23 years, during examination after passed pneumonia, underwent echocardiography wich revealed an aneurysm of right ventricle. Patient underwent further examination: MRI of heart in T1-WS and T2-WS, «gradient echo» and dynamical regime (Cine-SSFP) in standard positions. Demonstration of diverticulum is based on reconstruction imaging (MPR). Results: due to MRI data, in right ventricle we found a bulging 1,2х2,0 cm with clear contours, wich decreased in systole with myocardum of right ventricle - «true diverticulum of right ventricle». We marked difficulties in the diagnosis associated with the paucity of clinical manifestations.

Conclusions: MRI made it possible to study individual morphological anatomy of the diverticulum, to demonstrate and to assess in detail the topography that helped to make decisions on further management of the patient. 

 

References

1.      Cavalle-Garrido T., Cloutier A., Harder J., et al. Evolution of fetal ventricular aneurysms and diverticula of the heart: an echocardiographic study. Am. J. Perinatol. 1997; 14:393-400.

2.      Krasemann T., Gehrmann J., Fenge H., et al. Ventricular aneurysm or diverticulum? Clinical differential diagnosis. Pediatr. Cardio. 2001; 22:409-411.

3.      Rodts-Palenik S., Barrilleaux S., Jeanty Ph. Diverticulum of the right ventricle http://www.sonoworld.com/ fetus/page.aspx?id=1474

4.      Bankl H. Congenital malformation of heart and great vessels: Synopsis of Pathology, Embryology, and Natural History. Urban and Schwarzenberg. 1977; 263.

5.      Cumming G.R. Congenital diverticulum of the right ventricle. Am. J. Cardiol. 1969; 23:297.

6.      Wax J.R., Moran A., Pinette M.G., et al. Prenatal sonographic diagnosis of fetal right ventricular diverticulum. J. Ultrasound Med. 2007; 26(2):267-270.

7.      Pressoir R., Downing J. W. Congenital diverticula of the right ventricle of the heart: A case report. Journal of the National Medical Association. 1980; 72, 3: 262-264.

8.      Sangawa K., Aoki A., Yoshino T. Resection of a right ventricular diverticulum of fibrous type by off-pump cardiac surgery; report of a case. Kyobu Geka. 2009; 62(2):152-156.

9.      Farnsworth P.B., Lefkowitz M., Shehadi W., et al. Spontaneous rupture of fibrous diverticulum of the right ventricle. Am .J. Dis. Child. 1972; 123:248-250.

10.    Freedom R.M., Yoo S.J., Mikailian H. Cardiac diverticulum and aneurysm. The Natural and Modified History of Congenital Heart Disease. Blackwell Publishing. 2003:475-478.

11.    Rajs J., Thoren C., Kjellman M. Spontaneous rupture of a congenital diverticulum of the right ventricle in a 1-month-old child. Eur. J. Cardiol. 1977; 16(2): 131-137.

12.    Benatar A., Vorsselmans A. Foetal right ventricular outpouching associated with ventricular bigeminy. OA Case Reports. 2013; 12; 2(6):51.

13.    Marijon E., Ou Ph., Fermont L., et al. Diagnosis and outcome in congenital ventricular diverticulum and aneurysm. J. Thorac. Cardiovasc. Surg. 2006; 131: 433-437.

14.    Hamaoka, K., Onaka M., Tanaka T. Congenital ventricular aneurysm and diverticulum in children. Pediatric Cardiology 1987; 8:169-175.

15.    Uhl H.S. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bulletin of the JohnsHopkinsHospital. 1952; 91 (3): 197-209.

16.    Bharati S., Rowen M., Camarata S.J., et al. Diverticulum of the right ventricle. Arch. Pathol. 1975; 99:383-386.

17.    Carter J.B., Van Tassel R.A., Moller J.H., et al. Congenital diverticulum of the right ventricle. Association with pulmonary stenosis and ventricular septal defect. Am. J. Cardiol. 1971; 28:478.

18.    Cantrell J.R., Haller J.A., Ravitch M.M. A syndrome of congenital defects involving the abdominal wall, sternum, diaphragm, pericardium, and heart. Surg, Gynecol, Obstet. 1958; 107:602-614.

19.    Okereke O.U., Cooley D.A., Frazier O.H. Congenital diverticulum of the ventricle. J. Thorac. Cardiovasc. Surg. 1986; 91:208-214.

20.    McAulife F.M., Hornberger L.K., Johnson J., et al. Cardiac diverticulum with pericardial effusion: report of two new cases treated by in utero pericardiocentesis and a review of the literature. Ultrasound Obstet. Gynecol. 2005; 25:401-404.

21.    Treistman B., Cooley D.A., Lufschanowski R., Leachman R.D. Diverticulum or aneurysm of left ventricle. Am. J. Cardiol. 1973; 32:119-123.

22.    Paronetto F., Strauss L. Aneurysm of the left ventricle due to congenital muscle defect in an infant: report of a case with discussion of pathogenesis of associated endocardial fibroelastosis. Am. J. Cardiol. 1963; 12:721-729.

23.    Archbold R.A., Robinson N.M., Mills P.G. Long-term follow-up of a true contractile left ventricular diverticulum. Am. J. Cardiol. 1999; 83:810-813.

24.    Hornberger L.K., Dalvi B., Benacerraf B. Prenatal sonographic detection of cardiac aneurysms and diverticula. J. Ultrasound Med. 1994; 13:967-970.

25.    Carrard C., Massardier J., Pangaud N. Fetal right ventricular diverticulum with pericardial effusion: report of a new case treated by in utero pericardiocentesis. Pediatr. Cardiol. 2010; 31(6):891-893.

26.    Bogaert J. Dymarkowski S., Taylor A.M. Clinical Cardiac MRI. Springer. 2005; 563.

27.    O’Donnell D.H., Abbara S., Chaithiraphan V., et al. Cardiac Tumors: Optimal Cardiac MR Sequences and Spectrum of Imaging Appearances. AJR. 2009; 193: 377-387.

28.    Finn J.P., Nael K., Deshpande V., et al. Cardiac MR imaging: state of the technology. Radiology. 2006; 241:338-354.

29.    Suilen C., Friedli B., Rutishauser W. Congenital intrathoracic left ventricular diverticulum in an adult. Chest. 1990; 98:750-751.

30.    Evans W., Madrid A., Castillo W., et al. All cardiac right ventricular outpouches are not created equal. Pediatr Cardiol. 2009; 30(7):954-957.

 

 

Abstract:

Despite the fact that so far in the literature, many cases of endovascular closure of paravalvular leak (PVL), this type of intervention is unusual and is associated with a complex technical issues. In addition, the majority of publications devoted to the correction of mitral and aortic PVL, while the description of the closing of the tricuspid valve (TV) PVL are rare.

Below is a description of our first experience of endovascular correction of TV PVL in 54 years ole patient, who underwent TV repair with «Neokor-32» - supporting ring as a correction of atrial septal defect, TV insufficiency One year after surgery the patient reported a decrease in physical activity tolerance. Echocardiography diagnosed hemodynamically significant PVL of TV, 6mm size with leakage between the left ventricle and the right atrium and formation of pulmonary hypertension. PVL was successfully treated by endovascular correction with using of device for closure of ventricular septal defect.  

 

References

1.     Galea A. et al. Practical applications of digital tomosynthesis of the chest. Clinical radiology. 2014; 69(4): 424-430.

2.     de Koste J. R. S. et al. Digital tomosynthesis (DTS) for verification of target position in early stage lung cancer patients. Medical physics. 2013; 40(9): 091904.

3.     Dobbins III J. T. et al. Digital tomosynthesis of the chest for lung nodule detection: interim sensitivity results from an ongoing NIH-sponsored trial. Medical physics. 2008; 35(6): 2554-2557.

4.     Vikgren J. et al. Comparison of Chest Tomosynthesis and Chest Radiography for Detection of Pulmonary Nodules: Human Observer Study of Clinical Cases 1. Radiology. 2008; 249(3): 1034-1041.

5.     Quaia E. et al. Digital tomosynthesis as a problemsolving imaging technique to confirm or exclude potential thoracic lesions based on chest X-ray radiography. Academic radiology. 2013; 20(5): 546-553.

6.     Jung H. N. et al. Digital tomosynthesis of the chest: utility for detection of lung metastasis in patients with colorectal cancer. Clinical radiology. 2012; 67(3): 232-238.

7.     Nikitin M. M. Possibilities of digital tomosynthesis in the diagnosis of various forms of pulmonary tuberculosis. REJR. 2016; 6 (1): 35-47. [In Russ].

8.     F.Kovach F., Zhebek Z. X-ray anatomical basics of lungs’ examinations. Budapest, 1958; 364 p. [In Russ].

9.     Trofimova T. N. ed. Human X-ray anatomy. SPb.: Publishing house SPbMAPO. 2005; 496 p. [In Russ].

10.   Sapin M. R. ed. Human Anatomy. Moscow, M.: Medicine. 2001; 640 p. [In Russ].

11.   Sinelnikov R. D., Sinelnikov Ya. R. Atlas of human anatomy. M.: Medicine. 1996; 344 p. [In Russ].

12.   Kokov L. S., ed. X-ray Atlas of comparative anatomy. M.: Radiology-Press., 2012; 388 p. [In Russ].

 

 

 

Abstract:

Aim: was to improve the efficiency of diagnosis of patients with coronary heart disease, by estimating of possibilities of cardiac multislice computed tomography in comparison with coronary angiography.

Materials and methods: study included 64 patients (18 women and 46 men, mean age 62,4 ± 9,5 years) with a high risk of developing coronary heart disease. In 34 patients - myocardial infarction in anamnesis (18 patients - in pool right coronary artery in 16 patients - in left anterior descending artery). Clinics of angina pectoris - in 40 patients (functional class (FC) I - 10; FC II - 22, FC III - in 6, FC IV - 2 patients). Selection criteria: the absence of disease progression for at least 6 weeks, and at least 3 months of optimal treatment. All patients underwent cardiac MSCT at 256-slice CT scanner. Obtained data was compared with data of reference method - x-ray coronary angiography.

Results: comparison of MSCT coronary angiography with invasive data showed a high comparability of results of two methods in the evaluation of coronary artery disease. It was revealed that discrepancies between cardiac MSCT and CAG in detection of hemodynamically insignificant stenoses ranging from 0 to 4%, hemodynamically significant stenoses - from 0 to 2.6%, subtotal stenosis - from 0 to 1%, occlusions - 0%. The presence of strong correlations between data of cardiac MSCT and coronary angiography of stenosis, demonstrated the high quality of MSCT imaging of coronary artery segments in the examination with a variety of modes of application method.

Conclusion: multislice computed tomography is a highly effective method for diagnosing of structural and anatomic changes of coronary arteries in patients with coronary heart disease.

 

References

1.     Chazov E.I. Perspektivy kardiologii v svete progressa fundamental'noj nauki [Cardiology prospects in sight of the progress of fundamental science.]. Ter. arhiv. 2009;9:5-8 [In Russ].

2.     Kokov L.S., Shutihina I.V., Timina I.E. Ispol'zovanie ul'trazvukovyh tehnologij v ocenke ateroskleroticheskih porazhenij sosudistoj stenki [The use of ultrasonic technology in the assessment of atherosclerotic lesions of the vascular wall.]. Molekuljarnaja medicina. 2013;4:15-25 [In Russ].

3.     Sinicyn V.E., Stukalova O.V., Docenko Ju.A. i dr. Kontrastnaja magnitno-rezonansnaja tomografija v ocenke rubcovyh porazhenij miokarda u bol'nyh IBS[Contrast magnetic resonance imaging in the evaluation of myocardial scarring lesions in patients with coronary artery disease.]. Diagnosticheskaja i intervencionnaja radiologija. 2009;3 (4):23-31 [In Russ].

4.     Fedotenkov I.S., Gagarina N.V., Veselova T.N., Sinicyn V.E., Ternovoj S.K. Kolichestvennyj analiz urovnja kal'cinoza koronarnyh arterij: sravnenie informativnosti mul'tispiral'noj komp'juternoj tomografii i jelektronno-luchevoj tomografii[Quantitative analysis of the level of calcification of the coronary arteries: comparison of informativeness of multislice computed tomography and electron beam tomography.]. Terapevticheskij arhiv. 2006;12:15-19 [In Russ].

5.     Ternovoj S.K., Veselova T.N., Sinicyn V.E. i dr. Rol' mul'tispiral'noj komp'juternoj tomografii v diagnostike infarkta miokarda [The role of multislice computed tomography in the diagnosis of myocardial infarction.]. Kardiologija. 2008; 1: 4-8 [In Russ].

6.     Sinicyn V.E., Ternovoj S.K., Ustjuzhanin D.V. i dr. Diagnosticheskoe znachenie KT-angiografii v vyjavlenii gemodinamicheski znachimyh stenozov koronarnyh arterij [The diagnostic value of CT angiography in the detection of hemodynamically significant stenoses of coronary arteries]. Kardiologija. 2008; 1: 9-14 [InRuss].

7.     Ustjuzhanin D.V., Veselova T.N., Sinicyn V.E. i dr. Cravnitel'nyj analiz diagnosticheskogo znachenija neinvazivnoj angiografii koronarnyh arterij s pomoshh'ju jelektronno-luchevoj i mul'tispiral'noj komp'juternoj tomografii [Comparative analysis of the diagnostic value of noninvasive coronary angiography using the electron beam and multislice computed tomography.]. Terapevticheskij arhiv. 2008; 4:12-15[In Russ].

8.     Veselova T.N., Merkulova I.N., Mironov V.M., Merkulov E.V., Ternovoj S.K., Ruda M.Ja. Neinvazivnaja ocenka ateroskleroticheskogo porazhenija koronarnyh arterij u bol'nyh s ostrym koronarnym sindromom metodom mul'tispiral'noj komp'juternoj tomografii[Noninvasive assessment of atherosclerotic lesions of coronary arteries in patients with acute coronary syndrome by multislice computed tomography.]. Medicinskaja vizualizacija. 2010; 4:100-109 [In Russ].

9.     Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013;111:510-515.

10.   Gaudio C., Pelliccia F., Evangelista A. et al. 320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and metaanalysis. Int. J. Cardiol. 2013;168:1562-1564.

11.   Fedotenkov I.S., Veselova T.N., Ternovoj S.K., Sinicyn V.E. Rol' mul'tispiral'noj komp'juternoj tomografii v diagnostike kal'cinoza koronarnyh arterij [The role of multislice computed tomography in the diagnosis of coronary artery calcification]. Kardiologicheskij vestnik. 2007; 11 (XIV): 45-48 [In Russ].

12.   Ternovoj S.K., Nikonova M.Je., Akchurin R.S. i dr. Vozmozhnosti mul'tispiral'noj komp'juternoj tomografii (MSKT) v ocenke koronarnogo rusla i ventrikulografii v sravnenii s intervencionnoj koronaroventrikulografiej [Possibilities of multislice computed tomography (MSCT) in the evaluation of coronary arteries and ventriculography in comparison with interventional coronaroventriculography.]. Rossijskij jelektronnyj zhurnal luchevoj diagnostiki. 2013;3 (9): 28-36 [In Russ].

13.   Ternovoj S.K., Veselova T.N. Vyjavlenie nestabil'nyh bljashek v koronarnyh arterijah s pomoshh'ju mul'tispiral'noj kompjuternoj tomografii [Identification of unstable plaques in coronary arteries using a multislice computed tomography.]. Rossijskij jelektronnyj zhurnal luchevoj diagnostiki. 2014:4(13):7- 14 [In Russ].

14.   Sabarudin A., Sun Z. Coronary CT angiography: Diagnostic value and clinical challenges. World J. Cardiol. 2013;26;5(12):473-483.

15.   Pelliccia F., Pasceri V., Evangelista A. et al. Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected. consecutive patients with suspected coronary artery disease. Int. J. Cardiovasc. Imaging. 2013;29(2):443-452.

16.   Obaid D.R., Calvert PA., Gopalan D. et al. Dualenergy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validation. J Cardiovasc Comput Tomogr. 2014; 8(3):230-237. [PubMed: 24939072]

17.   Gbaid D.R., CalvertPA., Gopalan D. et al. Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. Circ Cardiovasc Imaging. 2013;6(5):655-664. [PubMed: 23960215] 

18.   Stehli J., Clerc O.F., Fuchs T.A. et al. Impact of monochromatic coronary computed tomography angiography from single-source dual-energy CT oncoronary stenosis quantification. J Cardiovasc Comput Tomogr. 2016;10(2):135-140.

19.   DanadI., Hartaigh B., Min J.K. Dual-energy computed tomography for detection of coronary artery disease. Expert Rev Cardiovasc Ther. 2015;13(12):1345- 1356.

20.   Petranovic M., Soni A., Bezzera H. et al. Assessment of nonstenotic coronary lesions by 64-slice multidetector computed tomography in comparison to intravascular ultrasound: evaluation of nonculprit coronary lesions. J Cardiovasc. Comput. Tomogr. 2009;3(1):24-31.

21.   Leber A.W., Knez A., Becker A. et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J. Am. Coll. Cardiol. 2004;43(7):1241-1247.

22.   Wu Y, Zheng M., Zhao H. et al. Low-concentration contrast material for dual-source computed tomography coronary angiography by a combination of iterative reconstruction and low-tube-voltage technique: feasibility study. Zhonghua YiXueZaZhi. 2014;94(29):2260-2263.

 

 

 

Abstract:

Aim: was to estimate parameters of left ventricle (LV) perfusion and kinetics at ischemic chronic heart failure (CHF), which initial values are predictors of increased myocardial functional reserve and patients clinical status improvement as a result of revascularization.

Materials and methods: examined 157 patients (146 men and 11 women; age from 33 to 72 years) before and in 2 - 3 days after percutaneous coronary intervention with diagnosis: CAD, CHF with NYHA class III-IV echocardiography parameters of LV: ejection fraction less than 40%, end-diastolic volume is more than 200 ml. Perfusion and function disorders were estimated with use of ECG-gated single photon emission computed tomography (SPECT).

Results: in 48% of cases 6-minute walk test increased more than 150%; NYHA class decreased by 2 classes (group 1). In 52% cases 6-minute walk test increased less than 50% and the NYHA class decreased on 1 class or did not change (group 2). Comparison of initial LV condition and clinical effect revealed following conformities. The revascularization effect is limited not to extent of coronary blood flow recovery, but first of all a cardiac muscle condition, the quantitative relation of the functioning myocardium and a focal cardiosclerosis. Thus, critical size to define the favorable forecast of revascularization is perfusion disorder more than a half of LV and kinetics disorder more than a third of cardiac muscle volume. Prevalence of a cardiosclerosis over the functioning myocardium limits clinical effect of a revascularization and growth of a functional reserve.

Conclusion: degree of initial LV myocardium perfusion and movement disorders at patients with severe ischemic heart failure is the key indicator, influencing clinical efficiency of coronary intervention

 

References

1.     Ageev F.T., Belenkov Yu.N., Fomin I.V., et al. Rasprostranennost hronicheskoj serdechnoj nedostatochnosti v Evropejskoj chaste Rossijskoj Federacii - dannye JEPOHA-HSN [The prevalence of chronic heart failure in the European part of the Russian Federation - Data AGE-CHF]. Serdechnaya nedostatochnost. 2006;7(1):112-115 [In Russ].

2.     Bax J.J., Delgado V. Myocardialviability as integral-part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol. 2015 Apr;22(2): 229-45.

3.     Mareev V.Yu., Danielyan M.O., Belenkov Yu.N., Ot imeni rabochej gruppy issledovaniya JEPOHA-O-HSN. Sravnitelnaya harakteristika bolnyh s HSN v zavisimosti ot velichiny FV po rezultatam Rossijskogo mnogocentrovogo issledovaniya JEPOHA-O-HSN [On behalf of the working group study AGE-O-CHF. Comparative characteristics of patients with CHF, depending on the size of the PV on results of Russian studies mnogotsentrovogo AGE-O-CHF]. Serdechnaya nedostatochnost. 2006;7 (4):164-171 [In Russ].

4.     Samady H., Elefteriades J.A., Abbott B.G., et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298- 304.

5.     Patel H.C., Ellis S.G.Role of revascularization to improveleft ventricular function. Heart Fail Clin. 2015 Apr; 11(2):203-14.

6.     Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary. J Am Coll Cardiol 2013;62:1495-539.

7.     McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.

8.     Fonseca C., Morais H., Mota T., Matias F., Costa C., Gouveia-Oliveira A., Ceia F. EPICA Investigators. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail. 2004 Oct; 6(6):795-800, 821-2.

9.     Shabana A., El-Menyar A. Myocardial viability: what we knew and what is new. Cardiol Res Pract. 2012; 2012:607486.

10.   Ling L.F., Marwick T.H., Flores D.R., Jaber W.A.. Brunken R.C., Cerqueira M.D., Hachamovitch R.Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013 May 1;6(3):363-72.

11.   Schinkel A.F., Poldermans D., Rizzello V., Vanoverschelde J.L., Elhendy A., Boersma E., Roelandt J.R., Bax J.J. Why do patients with ischemiccardiomyopathy and a substantialamount of viablemyocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004 Feb;127(2):385-90.

12.   Mandegar M.H., Yousefnia M.A., Roshanali F., Rayatzadeh H., Alaeddini F. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):930-6.

13.   Beanlands R.S.B., Dawood F., Wen W.H. et al. Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990; 82:1802-1814.

14.   Rizzello V., Schinkel A.F., Bax J.J., et al. «Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model» Am J Cardiol. 2003 Jun 15;91 (12): 1406-9.

15.   Chestuhin V.V., Mironkov A.B., Bljahman F.A., Ostroumov E.N., Kolchanova S.G., Shkljar T.F., Azoev Je.T., Sahovskij S.A. Vlijanie polnoty revaskuljarizacii serdca na funkcional'noe sostojanie miokarda pri ishemicheskoj kardiomiopatii [Influence of completeness of coronary revascularization on the functional state of the myocardium in ischemic cardiomyopathy.]. Vestnik transplantologii i iskusstvennyh organov. 2013: 14(4):55-63 [In Russ].

16.   Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001; 104(Suppl 1):I314 -8.

authors: 

 

Abstract:

Aim: was to assess dynamics of strain (S) and strain rate (SR) of longitudinal, circular and radial fibers in patients with left ventricular (LV) aneurysm (LVA) before and in early stages after coronary artery bypass graft (CABG) using Velocity Vector Imaging.

Material and methods: in 270 segments LV in patients with LVA, S and SR of LV fibers was analyzed before and after CAB. Also analysis of S and SR was performed in patients with CABG and plastic of the LV (group 1, 144 segments) and in the group with CABG without plastic of the LV (group 2, 126 segments).

Results: a function of longitudinal, circular and radial fibers after CABG has improved in all patients. Only SR of radial fibers reached normal. In group 1 was received the positive dynamics from the longitudinal S and SR, and SR circular and radial fibers. In group 2 indicators of function of longitudinal and circular fibers remained without negative dynamics, but positive dynamics is observed only from the SR of the radial fibers. The SR of radial fibers in both groups was normalized.

Conclusion: improvement of LV function in all patients is due to the group I. It is important to study the LV function in patients with LVA depending on the type of surgery.

 

References

1.     Paramonova T.I., Basylev V.V., Vdovkin A.V., Palkova V.A., Karpuchin V.G. Vliyanie operacij rekonstrukcii levogo zheludochka na funkcional'nye i ob"emnye pokazateli u bol'nyh s postinfarktnoj anevrizmoj. [The impact of operations on the reconstruction of the left ventricle function and volume indices in patients with postinfarction aneurism.] Diagnostic radiology and radiotherapy. 2015; 1(6): 74-81 [In Russ].

2.     Dor V., Di Donato M., Civaya F. Postinfarktnoe remodelirovanie levogo zheludochka: magnitno-rezonansnaya tomografiya dlya ocenki patofiziologii posle rekonstrukcii levogo zheludochka. [Post myocardial infarct remodeling: role of magnetic resonance imaging for the assessment of its pathophysiology after left ventricular reconstruction.] Thoracic and Cardiovascular Surgery. 2014; 3: 14-27 [In Russ].

3.     Chernyavskii A.M., Kareva Yu. E., Denisova M.A.,Efendiev V.U. Problema predoperacionnogo modelirovaniya levogo zheludochka. [The problem of preoperative left ventricular modeling.] Cardiology and Cardiovascular Surgery. 2015; 2: 4-7 [In Russ].

4.     Carasso Sh., Biaggi P., Rakowski H. et al. Velocity Vector Imaging: Standart Tissue - Tracking Results Acquired in Normals - The VVI - Strain Study. Journal of the American Society of Echocardiography. 2012; 25(5): 543-552.

5.    Alekhin M.N. Ul'trazvukovye metody ocenki deformacii miokarda i ih klinicheskoe znachenie. [Ultrasound estimation techniques and their clinical significance.] M.: Vidar-M, 2012; 88 p [In Russ].

6.     Rostamzadeh A., Shojaeifard M., Rezaei Y, et al. Diagnostic accuracy of myocardial deformation indices for detecting high risk coronary artery disease in patient without regional wall motion abnormality. Int J Clin Exp Med. 2015; 8(6): 9412-9420.

7.    Pavlyukova E.N., Karpov R.S Deformaciya, rotaciya i povorot po osi levogo zheludochka u bol'nyh ishemicheskoj bolezn'yu serdca s tyazheloj levozheludochkovoj disfunkciej. [Deformation, rotation, and axial torsion of the left ventricle in coronary heart disease patients with its severe dysfunction. ] Terapevticeskij arhiv. 2012;9: 11-16 [In Russ].

8.     Lang R.M., Badano L.P, Mor-Avi V., et al. Recommendation for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. 2015; 16: 233-271.

9.     Helsinki declaration of VMA: Eticheskie principy medicinskih issledovanij s privlecheniem cheloveka, prinyataya 18-j General'noj Assambleej VMA (Hel'sinki, Finlyandiya, iyun’ 1964 п.) [Ethical principles of medical researches with involvement of the person, Accepted by the 18th General Assembly of VMA (Helsinki, Finland, June, 1964). ]http://www. psychiatr.ru/lib/helsinki_declaration.php. (date of the address: 25.05.2015 г.) [In Russ]

 

 

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы